Kansas 2023-2024 Regular Session

Kansas Senate Bill SB555 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	Session of 2024
2	2	SENATE BILL No. 555
3	3	By Committee on Federal and State Affairs
4	4	3-18
5	5	AN ACT concerning health and healthcare; relating to medical cannabis;
6	6	creating the medical cannabis pilot program act; authorizing the
7	7	secretary of health and environment to enter into contracts for the
8	8	limited cultivation, processing and distribution of medical cannabis for
9	9	patient use upon a physician's recommendation; imposing terms and
10	10	conditions for such contracts; establishing requirements for physician
11	11	certifications recommending medical cannabis use; levying an excise
12	12	tax on the retail sale of medical cannabis; establishing the medical
13	13	cannabis refund fund and the medical cannabis research and education
14	14	fund; creating the crime of unlawful storage of medical cannabis;
15	15	making exceptions to the crimes of unlawful manufacture and
16	16	possession of controlled substances; amending K.S.A. 21-5703, 21-
17	17	5705, 21-5706, 21-5707, 21-5709, 21-5710, 23-3201, 38-2269, 44-501,
18	18	79-5201 and 79-5210 and K.S.A. 2023 Supp. 65-1120 and 65-28b08
19	19	and repealing the existing sections.
20	20	Be it enacted by the Legislature of the State of Kansas:
21	21	New Section 1. The provisions of sections 1 through 27, and
22	22	amendments thereto, shall be known and may be cited as the medical
23	23	cannabis pilot program act.
24	24	New Sec. 2. As used in the medical cannabis pilot program act,
25	25	section 1 et seq., and amendments thereto:
26	26	(a) "Academic medical center" means a medical school and its
27	27	affiliated teaching hospitals and clinics.
28	28	(b) "Cannabinoid" means any of the chemical compounds that are
29	29	produced naturally in the plant cannabis sativa that can bind on the
30	30	cannabinoid receptors in cells.
31	31	(c) (1) "Cannabis" means the plant cannabis sativa and all parts
32	32	thereof, whether growing or not, including the seeds, the resin extracted
33	33	from any part of the plant and any compound, manufacture, salt,
34	34	derivative, mixture or preparation of the plant, its seeds or resin.
35	35	(2) "Cannabis" does not include:
36	36	(A) (i) The mature stalks of the plant;
37	37	(ii) fiber produced from mature stalks;
38	38	(iii) oil or cake made from the seeds of the plant;
39	39	(iv) any other compound, manufacture, salt, derivative, mixture or
40	40	1
41	41	2
42	42	3
43	43	4
44	44	5
45	45	6
46	46	7
47	47	8
48	48	9
49	49	10
50	50	11
51	51	12
52	52	13
53	53	14
54	54	15
55	55	16
56	56	17
57	57	18
58	58	19
59	59	20
60	60	21
61	61	22
62	62	23
63	63	24
64	64	25
65	65	26
66	66	27
67	67	28
68	68	29
69	69	30
70	70	31
71	71	32
72	72	33
73	73	34
74	74	35
75	75	36 SB 555 2
76	76	preparation of the mature stalks, fiber, oil or cake, except the resin
77	77	extracted from the mature stalks; or
78	78	(v) the sterilized seed of the plant that is incapable of germination;
79	79	(B) any substance listed in schedules II through V of the uniform
80	80	controlled substances act;
81	81	(C) drug products approved by the United States food and drug
82	82	administration as of July 1, 2024;
83	83	(D) cannabidiol (other trade name: 2-[3-methyl-6-(1-methylethenyl)-
84	84	2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol); or
85	85	(E) industrial hemp, as defined in K.S.A. 2-3901, and amendments
86	86	thereto, when cultivated, produced, possessed or used for activities
87	87	authorized by the commercial industrial hemp act.
88	88	(d) "Caregiver" means an individual designated on a medical
89	89	cannabis certificate who is authorized to purchase and possess medical
90	90	cannabis on behalf of a patient named in such medical cannabis certificate.
91	91	(e) "Cultivate" means the same as defined in K.S.A. 65-4101, and
92	92	amendments thereto.
93	93	(f) "Dispense" or "dispensing" means to sell or deliver medical
94	94	cannabis or medical cannabis products to a patient or caregiver, including
95	95	the packaging and labeling required for such delivery.
96	96	(g) "Distribution hub" means a premises owned and operated by a
97	97	medical cannabis operator or a pharmacy for the storage, distribution, sale
98	98	and delivery of medical cannabis and medical cannabis products to
99	99	patients and caregivers.
100	100	(h) "Medical cannabis" means cannabis that is cultivated, processed,
101	101	tested, dispensed, possessed or used for a medical purpose.
102	102	(i) "Medical cannabis certificate" means a document issued by a
103	103	physician pursuant to section 20, and amendments thereto, recommending
104	104	the use of medical cannabis by the patient named in such document.
105	105	(j) "Medical cannabis operator" or "operator" means a person who
106	106	cultivates, processes, stores, distributes, sells and delivers medical
107	107	cannabis and medical cannabis products in accordance with a contract with
108	108	the secretary pursuant to section 4, and amendments thereto.
109	109	(k) "Medical cannabis product" means a product that contains
110	110	cannabinoids that have been extracted from plant material or the resin
111	111	therefrom by physical or chemical means and is intended for
112	112	administration to a patient.
113	113	(l) "Medical cannabis waste" means:
114	114	(1) Unused, surplus, returned or out-of-date medical cannabis or
115	115	medical cannabis product;
116	116	(2) recalled medical cannabis or medical cannabis product;
117	117	(3) plant debris of the plant of cannabis sativa, including dead plants
118	118	and all unused plant parts and roots; and
119	119	1
120	120	2
121	121	3
122	122	4
123	123	5
124	124	6
125	125	7
126	126	8
127	127	9
128	128	10
129	129	11
130	130	12
131	131	13
132	132	14
133	133	15
134	134	16
135	135	17
136	136	18
137	137	19
138	138	20
139	139	21
140	140	22
141	141	23
142	142	24
143	143	25
144	144	26
145	145	27
146	146	28
147	147	29
148	148	30
149	149	31
150	150	32
151	151	33
152	152	34
153	153	35
154	154	36
155	155	37
156	156	38
157	157	39
158	158	40
159	159	41
160	160	42
161	161	43 SB 555 3
162	162	(4) any wastewater generated during cultivation and processing.
163	163	(m) "Patient" means an individual who possesses a medical cannabis
164	164	certificate authorizing such individual to purchase, possess and consume
165	165	medical cannabis or medical cannabis products in accordance with this act.
166	166	(n) "Person" means any natural person, corporation, limited liability
167	167	company, limited company, partnership or limited partnership.
168	168	(o) "Pharmacy" means a premises or other site that employs one or
169	169	more licensed pharmacists, as defined in K.S.A. 65-1626, and amendments
170	170	thereto, to dispense drugs that are offered for sale and that is registered
171	171	pursuant to K.S.A. 65-1643, and amendments thereto.
172	172	(p) "Physician" means an individual licensed to practice medicine and
173	173	surgery in this state.
174	174	(q) "Plant" means the plant cannabis sativa produced from a clone or
175	175	seed.
176	176	(r) (1) "Plant material" means the leaves, stems, buds and flowers of
177	177	the plant cannabis sativa.
178	178	(2) "Plant material" does not include seedlings, seeds, clones, stalks
179	179	or roots of the plant or the weight of any non-cannabis ingredients
180	180	combined with cannabis.
181	181	(s) "Postsecondary educational institution" means the same as defined
182	182	in K.S.A. 74-3201b, and amendments thereto.
183	183	(t) "Process" or "processing" means the extraction of cannabinoids
184	184	from medical cannabis for the production of medical cannabis products.
185	185	(u) "Qualifying medical condition" means any of the following:
186	186	(1) Acquired immune deficiency syndrome;
187	187	(2) amyotrophic lateral sclerosis;
188	188	(3) autism;
189	189	(4) cancer;
190	190	(5) chronic traumatic encephalopathy;
191	191	(6) Crohn's disease;
192	192	(7) epilepsy or another seizure disorder;
193	193	(8) fibromyalgia;
194	194	(9) multiple sclerosis;
195	195	(10) Parkinson's disease;
196	196	(11) post-traumatic stress disorder;
197	197	(12) sickle cell anemia;
198	198	(13) spinal cord disease or injury;
199	199	(14) traumatic brain injury;
200	200	(15) ulcerative colitis; or
201	201	(16) pain that is either chronic and severe or intractable.
202	202	(v) "Secretary" means the secretary of health and environment.
203	203	(w) "Smoking" means the act of consuming cannabis through
204	204	combustion and inhalation.
205	205	1
206	206	2
207	207	3
208	208	4
209	209	5
210	210	6
211	211	7
212	212	8
213	213	9
214	214	10
215	215	11
216	216	12
217	217	13
218	218	14
219	219	15
220	220	16
221	221	17
222	222	18
223	223	19
224	224	20
225	225	21
226	226	22
227	227	23
228	228	24
229	229	25
230	230	26
231	231	27
232	232	28
233	233	29
234	234	30
235	235	31
236	236	32
237	237	33
238	238	34
239	239	35
240	240	36
241	241	37
242	242	38
243	243	39
244	244	40
245	245	41
246	246	42
247	247	43 SB 555 4
248	248	(x) "State contracted laboratory" means a laboratory that has entered
249	249	into a contract with the secretary pursuant to section 7, and amendments
250	250	thereto.
251	251	(y) "Tetrahydrocannabinol" or "THC" means the primary
252	252	psychoactive cannabinoid in cannabis.
253	253	(z) "Tetrahydrocannabinol content" means the sum of the amount of
254	254	tetrahydrocannabinol and 87.7% of the amount of tetrahydrocannabinolic
255	255	acid present in the product.
256	256	(aa) "Tetrahydrocannabinolic acid" means the acidic form of THC.
257	257	(bb) "Vaporization" means consumption of medical cannabis products
258	258	through inhalation of vaporized products.
259	259	New Sec. 3. (a) No person shall grow, harvest, process, sell, barter,
260	260	transport, deliver, furnish or otherwise possess any form of cannabis,
261	261	except as specifically provided in the medical cannabis pilot program act
262	262	or the commercial industrial hemp act, K.S.A. 2-3901 et seq., and
263	263	amendments thereto.
264	264	(b) Nothing in the medical cannabis pilot program act shall be
265	265	construed to:
266	266	(1) Require a physician to recommend that a patient use medical
267	267	cannabis to treat a qualifying medical condition;
268	268	(2) permit the use, possession or administration of medical cannabis
269	269	other than as authorized by this act;
270	270	(3) permit the use, possession or administration of medical cannabis
271	271	on federal land located in this state;
272	272	(4) require any public place to accommodate a patient's use of
273	273	medical cannabis;
274	274	(5) prohibit any public place from accommodating a patient's use of
275	275	medical cannabis; or
276	276	(6) restrict research related to cannabis conducted at a postsecondary
277	277	educational institution, academic medical center or private research and
278	278	development organization as part of a research protocol approved by an
279	279	institutional review board or equivalent entity.
280	280	New Sec. 4. (a) There is hereby established the medical cannabis
281	281	pilot program to be administered by the secretary of health and
282	282	environment.
283	283	(b) The secretary may enter into contracts with medical cannabis
284	284	operators for the cultivation and processing of medical cannabis and
285	285	medical cannabis products in this state. Each contract shall contain such
286	286	terms and conditions as required by this act and such other terms and
287	287	conditions as may be required and negotiated by the secretary. No term or
288	288	condition of any such contract shall conflict, either directly or indirectly,
289	289	with the provisions of this act. Each contract shall expire on or before July
290	290	1, 2029.
291	291	1
292	292	2
293	293	3
294	294	4
295	295	5
296	296	6
297	297	7
298	298	8
299	299	9
300	300	10
301	301	11
302	302	12
303	303	13
304	304	14
305	305	15
306	306	16
307	307	17
308	308	18
309	309	19
310	310	20
311	311	21
312	312	22
313	313	23
314	314	24
315	315	25
316	316	26
317	317	27
318	318	28
319	319	29
320	320	30
321	321	31
322	322	32
323	323	33
324	324	34
325	325	35
326	326	36
327	327	37
328	328	38
329	329	39
330	330	40
331	331	41
332	332	42
333	333	43 SB 555 5
334	334	(c) The secretary shall not enter into a contract pursuant to subsection
335	335	(b) with more than four medical cannabis operators at any one time. For
336	336	the privilege of being a medical cannabis operator, each medical cannabis
337	337	operator shall agree to pay the secretary an annual amount of not less than
338	338	$50,000.
339	339	(d) Each contract shall permit the medical cannabis operator to
340	340	commence operations in accordance with this act on July 1, 2024, or as
341	341	soon thereafter as the facilities of such medical cannabis operator used for
342	342	the cultivation or processing of medical cannabis and medical cannabis
343	343	products are deemed compliant with the provisions of this act by the
344	344	secretary.
345	345	(e) No contract shall be assignable except as mutually agreed to by
346	346	the medical cannabis operator and the secretary. Any assignee shall satisfy
347	347	the requirements of section 5, and amendments thereto, prior to the
348	348	execution of any agreement to assign such contract.
349	349	(f) If the secretary finds that a medical cannabis operator is in breach
350	350	of any provision of the contract or in violation of any provision of this act,
351	351	the secretary shall provide written notice of such breach or violation to
352	352	such medical cannabis operator. The medical cannabis operator shall have
353	353	30 days from the receipt of such written notice to remedy the breach or
354	354	violation, unless the written notice provides a longer period of time or the
355	355	parties to the contract agree to a longer period of time. If the medical
356	356	cannabis operator fails to remedy a breach or violation within the specified
357	357	period of time, the secretary may terminate such contract.
358	358	New Sec. 5. (a) All persons, if individuals, contracting with the
359	359	secretary pursuant to section 4, and amendments thereto, and all members,
360	360	partners, directors, managers, shareholders and officers of any other person
361	361	shall:
362	362	(1) Be a citizen of the United States;
363	363	(2) have not been convicted of a felony under the laws of this state,
364	364	any other state or the United States;
365	365	(3) be at least 21 years of age;
366	366	(4) not intend to carry on the authorized business activities or conduct
367	367	such business activities on behalf of or for the primary benefit of another
368	368	person who does not satisfy the requirements of this section;
369	369	(5) own or lease the premises on which the authorized business
370	370	activities will be conducted; and
371	371	(6) have been a resident of this state since July 1, 2021, except if the
372	372	person is a business entity, then not less than 80% of the total equity of
373	373	such business entity shall be held by individuals who have been a resident
374	374	of this state since July 1, 2021.
375	375	(b) At least one director, manager or officer of a business entity
376	376	contracting with the secretary pursuant to section 4, and amendments
377	377	1
378	378	2
379	379	3
380	380	4
381	381	5
382	382	6
383	383	7
384	384	8
385	385	9
386	386	10
387	387	11
388	388	12
389	389	13
390	390	14
391	391	15
392	392	16
393	393	17
394	394	18
395	395	19
396	396	20
397	397	21
398	398	22
399	399	23
400	400	24
401	401	25
402	402	26
403	403	27
404	404	28
405	405	29
406	406	30
407	407	31
408	408	32
409	409	33
410	410	34
411	411	35
412	412	36
413	413	37
414	414	38
415	415	39
416	416	40
417	417	41
418	418	42
419	419	43 SB 555 6
420	420	thereto, shall have held a license as a hemp producer under the commercial
421	421	industrial hemp act, K.S.A. 2-3901 et seq., and amendments thereto, for
422	422	two years immediately prior to the execution of such contract. Such
423	423	individual shall also have served as a director, manager or officer of such
424	424	business entity during the same two-year period.
425	425	(c) All persons contracting with the secretary pursuant to section 4,
426	426	and amendments thereto, who are not individuals shall provide to the
427	427	secretary:
428	428	(1) A certificate of good standing;
429	429	(2) a copy of such person's bylaws, operating agreement or other
430	430	document providing for the governance of such person; and
431	431	(3) a certified document indicating:
432	432	(A) Each individual who holds an ownership interest in such person
433	433	and each individual who holds an ownership interest in any business entity
434	434	that holds an ownership interest in such person;
435	435	(B) the percentage of ownership interest of each such individual or
436	436	business entity; and
437	437	(C) the residential address of each such individual.
438	438	(d) Any contract entered into pursuant to section 4, and amendments
439	439	thereto, shall prohibit:
440	440	(A) Any compensation, fee, expense or similarly characterized non-
441	441	equity payment that is contingent on or otherwise determined in a manner
442	442	that factors in profits, sales, revenue or cash flow of any kind relating to
443	443	the operation of business activities by a medical cannabis operator,
444	444	including, but not limited to, profit-based consulting fees and percentage
445	445	rent payments;
446	446	(B) any convertible notes or other non-equity instruments used to
447	447	finance the authorized business activities of a medical cannabis operator if
448	448	the beneficiary of any such instrument is domiciled outside of this state;
449	449	and
450	450	(C) distributions by an operator to any person domiciled outside of
451	451	this state that exceed such recipient's pro rata share of the net profits
452	452	earned by a medical cannabis operator based on the recipient's ownership
453	453	interest in such medical cannabis operator. Each operator shall disclose to
454	454	the secretary any financial instrument, equity or distribution structure that
455	455	provides for the distribution of moneys by such operator to persons
456	456	domiciled, incorporated or otherwise organized outside of this state.
457	457	New Sec. 6. (a) Each medical cannabis operator may operate one or
458	458	more facilities for the cultivation of medical cannabis. Such facilities may
459	459	be contiguous to each other or located on separate parcels of real property.
460	460	A medical cannabis operator shall only:
461	461	(1) Cultivate and harvest medical cannabis flower in facilities that are
462	462	completely enclosed and windowless;
463	463	1
464	464	2
465	465	3
466	466	4
467	467	5
468	468	6
469	469	7
470	470	8
471	471	9
472	472	10
473	473	11
474	474	12
475	475	13
476	476	14
477	477	15
478	478	16
479	479	17
480	480	18
481	481	19
482	482	20
483	483	21
484	484	22
485	485	23
486	486	24
487	487	25
488	488	26
489	489	27
490	490	28
491	491	29
492	492	30
493	493	31
494	494	32
495	495	33
496	496	34
497	497	35
498	498	36
499	499	37
500	500	38
501	501	39
502	502	40
503	503	41
504	504	42
505	505	43 SB 555 7
506	506	(2) conduct cultivation activities in such facilities on an aggregate of
507	507	25,000 square feet of floor area for mature, flowering cannabis plants.
508	508	Such floor area limitation shall not apply to any areas that do not contain
509	509	mature, flowering cannabis plants, including areas containing mother
510	510	plants, vegetative plants, clones or seedlings; and
511	511	(3) use single horizontal tiers for mature, flowering plants when
512	512	cultivating medical cannabis.
513	513	(b) Each medical cannabis operator may operate one or more
514	514	facilities for the processing of medical cannabis into medical cannabis
515	515	products. A medical cannabis operator shall only:
516	516	(1) Process medical cannabis in a secure, completely enclosed
517	517	facility;
518	518	(2) use extraction methods that do not involve any high-pressure
519	519	systems, potentially explosive systems or non-water or non-oil solvents,
520	520	including, but not limited to, butane, propane, ethanol or carbon dioxide;
521	521	and
522	522	(3) produce only those medical cannabis products that are permitted
523	523	for dispensing under section 12, and amendments thereto.
524	524	(c) A medical cannabis operator may commence cultivation activities
525	525	prior to the execution of a contract pursuant to section 4, and amendments
526	526	thereto, if the secretary issues a letter of intent to enter into a contract with
527	527	such medical cannabis operator. Such letter of intent shall specify the
528	528	medical cannabis operator the secretary intends to enter into a contract
529	529	with, the facility premises that may commence cultivation activities prior
530	530	to the execution of such contract and the date certain on which such
531	531	cultivation activities shall cease if no contract has been executed as of such
532	532	date. If a contract has not been executed prior to the date specified in the
533	533	letter of intent, such medical cannabis operator shall cease cultivation
534	534	activities until a contract is executed between such medical cannabis
535	535	operator and the secretary.
536	536	(d) A medical cannabis operator may contract with a person licensed
537	537	as a hemp processor under the commercial industrial hemp act, K.S.A. 2-
538	538	3901 et seq., and amendments thereto, to process medical cannabis into
539	539	medical cannabis products. All medical cannabis products produced
540	540	pursuant to such contract shall be subject to the testing provisions of
541	541	section 7, and amendments thereto, and the tracking requirements of
542	542	section 14, and amendments thereto.
543	543	(e) Each medical cannabis operator shall have an agreement with a
544	544	qualified company that performs audits of industrial safety practices and
545	545	hygiene measures. Prior to the commencement of operations, each facility
546	546	shall be determined compliant with minimum safety standards in hazard
547	547	communication, respiratory protection and emergency action planning.
548	548	(f) No medical cannabis or medical cannabis products shall be
549	549	1
550	550	2
551	551	3
552	552	4
553	553	5
554	554	6
555	555	7
556	556	8
557	557	9
558	558	10
559	559	11
560	560	12
561	561	13
562	562	14
563	563	15
564	564	16
565	565	17
566	566	18
567	567	19
568	568	20
569	569	21
570	570	22
571	571	23
572	572	24
573	573	25
574	574	26
575	575	27
576	576	28
577	577	29
578	578	30
579	579	31
580	580	32
581	581	33
582	582	34
583	583	35
584	584	36
585	585	37
586	586	38
587	587	39
588	588	40
589	589	41
590	590	42
591	591	43 SB 555 8
592	592	cultivated or processed by a medical cannabis operator for personal use by
593	593	any member, partner, director, manager, officer, shareholder or employee
594	594	of such medical cannabis operator, or any family member or other
595	595	individual residing in the household of such member, partner, director,
596	596	manager, officer, shareholder or employee.
597	597	New Sec. 7. (a) No batch of medical cannabis or medical cannabis
598	598	products shall be sold unless a sample from such batch has been tested and
599	599	certified for use or consumption by the state contracted laboratory. Each
600	600	contract shall specify batch size, testing and certification requirements and
601	601	the identity of the state contracted laboratory. The batch size for medical
602	602	cannabis shall not be more than 10 pounds and the batch size for medical
603	603	cannabis products shall not be more than five liters or the equivalent of
604	604	such amount.
605	605	(b) The secretary shall enter into a contract with a laboratory for the
606	606	purpose of conducting compliance and quality assurance testing of
607	607	medical cannabis and medical cannabis products produced by medical
608	608	cannabis operators. The state contracted laboratory shall:
609	609	(1) At the time of execution of the contract with the secretary, operate
610	610	a laboratory in another state that tests cannabis and that holds an ISO
611	611	17025 accreditation;
612	612	(2) not be owned, in whole or in part, by any person who is a medical
613	613	cannabis operator or who has any ownership interest in a medical cannabis
614	614	operator;
615	615	(3) not have any member of its board of directors who is a medical
616	616	cannabis operator or who has any ownership interest in a medical cannabis
617	617	operator; and
618	618	(4) not employ any individual or any spouse, parent, child, sibling or
619	619	spouse of a child or sibling who is a medical cannabis operator or who has
620	620	any ownership interest in a medical cannabis operator.
621	621	(c) The state contracted laboratory shall develop testing standards and
622	622	procedures in consultation with the secretary. Such standards and
623	623	procedures shall include, but are not limited to, the following:
624	624	(1) The cleanliness and orderliness of the laboratory premises;
625	625	(2) the inspection, cleaning and maintenance of equipment and tools
626	626	used for the analysis of test samples;
627	627	(3) testing standards and procedures for cannabinoid potency,
628	628	terpene profiles and safe levels of contaminants;
629	629	(4) the methods for obtaining test samples and implementing an
630	630	inventory tracking system to ensure a secure chain of custody;
631	631	(5) controlled access areas for storage of medical cannabis and
632	632	medical cannabis product test samples, waste and reference standards;
633	633	(6) the establishment of a system to record and maintain all required
634	634	testing and analysis information, including test results, business records
635	635	1
636	636	2
637	637	3
638	638	4
639	639	5
640	640	6
641	641	7
642	642	8
643	643	9
644	644	10
645	645	11
646	646	12
647	647	13
648	648	14
649	649	15
650	650	16
651	651	17
652	652	18
653	653	19
654	654	20
655	655	21
656	656	22
657	657	23
658	658	24
659	659	25
660	660	26
661	661	27
662	662	28
663	663	29
664	664	30
665	665	31
666	666	32
667	667	33
668	668	34
669	669	35
670	670	36
671	671	37
672	672	38
673	673	39
674	674	40
675	675	41
676	676	42
677	677	43 SB 555 9
678	678	and operating processes;
679	679	(7) the possession, storage and use of reagents, solutions and
680	680	reference standards;
681	681	(8) the issuance of a certificate of analysis for each tested batch;
682	682	(9) the transport and disposal of unused medical cannabis, medical
683	683	cannabis products and waste;
684	684	(10) employment records and logs of laboratory personnel;
685	685	(11) a written standard operating procedure manual that is regularly
686	686	maintained and updated; and
687	687	(12) procedures for the immediate recall of medical cannabis or
688	688	medical cannabis products that are determined to be unsafe.
689	689	(d) Testing standards developed by the state contracted laboratory
690	690	shall establish compliance thresholds for each of the following categories:
691	691	(1) Microbials;
692	692	(2) mycotoxins;
693	693	(3) residual solvents;
694	694	(4) pesticides;
695	695	(5) moisture content; and
696	696	(6) heavy metals.
697	697	(e) All batches of medical cannabis or medical cannabis product that
698	698	are determined to be noncompliant with the testing thresholds shall be
699	699	either remediated or destroyed by the medical cannabis operator who
700	700	submitted the test sample for such batch. The state contracted laboratory
701	701	shall provide guidance on the method of remediation for noncompliant
702	702	batches. All remediated batches shall be resubmitted for testing to ensure
703	703	compliance after remediation has been completed.
704	704	(f) The state contracted laboratory shall also test the cannabinoid
705	705	content, terpene profile and tetrahydrocannabinol content of all batches.
706	706	(g) The state contracted laboratory may charge medical cannabis
707	707	operators for the testing services required under this act.
708	708	(h) On or before June 30, 2025, and each June 30 thereafter, the state
709	709	contracted laboratory shall submit a report to the secretary containing the
710	710	following information for the immediately preceding 12 months:
711	711	(1) The total amount of medical cannabis and medical cannabis
712	712	products tested, and the percentage certified as satisfying the requirements
713	713	for use and consumption;
714	714	(2) laboratory testing standards and procedures used and a description
715	715	of the relative success of such standards and procedures;
716	716	(3) a description of the relative success of the laboratory standards
717	717	and testing requirements required under the medical cannabis pilot
718	718	program; and
719	719	(4) any recommendations regarding any of the requirements of this
720	720	act that would improve the medical cannabis pilot program and any
721	721	1
722	722	2
723	723	3
724	724	4
725	725	5
726	726	6
727	727	7
728	728	8
729	729	9
730	730	10
731	731	11
732	732	12
733	733	13
734	734	14
735	735	15
736	736	16
737	737	17
738	738	18
739	739	19
740	740	20
741	741	21
742	742	22
743	743	23
744	744	24
745	745	25
746	746	26
747	747	27
748	748	28
749	749	29
750	750	30
751	751	31
752	752	32
753	753	33
754	754	34
755	755	35
756	756	36
757	757	37
758	758	38
759	759	39
760	760	40
761	761	41
762	762	42
763	763	43 SB 555 10
764	764	subsequent medical cannabis programs.
765	765	New Sec. 8. (a) (1) The secretary may enter into a contract with one
766	766	or more pharmacies to operate a distribution hub for the purpose of
767	767	dispensing medical cannabis and medical cannabis products in this state.
768	768	Each contract shall contain such terms and conditions as required by this
769	769	act and such other terms and conditions as may be required and negotiated
770	770	by the secretary. No term or condition of any such contract shall conflict,
771	771	either directly or indirectly, with the provisions of this act. Each contract
772	772	shall expire on or before July 1, 2029.
773	773	(2) For the privilege of operating a distribution hub, each pharmacy
774	774	shall agree to pay the secretary an annual amount of not less than $500.
775	775	(3) No contract shall be assignable except as mutually agreed to by
776	776	the pharmacy and the secretary.
777	777	(4) If the secretary finds that a pharmacy is in breach of any provision
778	778	of the contract or in violation of any provision of this act, the secretary
779	779	shall provide written notice of such breach or violation to such pharmacy.
780	780	The pharmacy shall have 30 days from the receipt of such written notice to
781	781	remedy the breach or violation unless the written notice provides a longer
782	782	period of time or the parties to the contract agree to a longer period of
783	783	time. If the pharmacy fails to remedy a breach or violation within the
784	784	specified period of time, the secretary may terminate such contract.
785	785	(b) On or before September 1, 2024, the secretary shall determine if
786	786	pharmacies are precluded from operating distribution hubs by federal law
787	787	or regulations. If the secretary determines that pharmacies are precluded
788	788	from operating distribution hubs, the secretary may enter into contracts
789	789	with one or more medical cannabis operators for the operation of
790	790	distribution hubs. A medical cannabis operator shall not operate more than
791	791	seven distribution hubs. The provisions of section 4, and amendments
792	792	thereto, shall apply to any contract entered into between the secretary and
793	793	a medical cannabis operator pursuant to this section.
794	794	(c) Each distribution hub may obtain medical cannabis and medical
795	795	cannabis products from one or more medical cannabis operators, including
796	796	the operator that owns and operates such distribution hub. A distribution
797	797	hub may sell and deliver medical cannabis and medical cannabis products
798	798	to patients and caregivers in accordance with subsection (b).
799	799	(d) When selling or delivering medical cannabis and medical
800	800	cannabis products the distribution hub shall:
801	801	(1) Dispense medical cannabis and medical cannabis products only to
802	802	a patient or caregiver who provides a valid medical cannabis certificate
803	803	and a valid driver's license, state-issued nondriver's identification card or
804	804	other government-issued photo identification card;
805	805	(2) verify that the patient or caregiver purchasing the medical
806	806	cannabis or medical cannabis products is the individual named on the
807	807	1
808	808	2
809	809	3
810	810	4
811	811	5
812	812	6
813	813	7
814	814	8
815	815	9
816	816	10
817	817	11
818	818	12
819	819	13
820	820	14
821	821	15
822	822	16
823	823	17
824	824	18
825	825	19
826	826	20
827	827	21
828	828	22
829	829	23
830	830	24
831	831	25
832	832	26
833	833	27
834	834	28
835	835	29
836	836	30
837	837	31
838	838	32
839	839	33
840	840	34
841	841	35
842	842	36
843	843	37
844	844	38
845	845	39
846	846	40
847	847	41
848	848	42
849	849	43 SB 555 11
850	850	medical cannabis certificate by using the valid photo identification
851	851	provided;
852	852	(3) ensure that the medical cannabis certificate submitted for such
853	853	patient or caregiver by such patient's physician matches the certificate
854	854	provided by such patient or caregiver;
855	855	(4) create and maintain records of all sales, including the type of
856	856	medical cannabis or medical cannabis product sold, the amount thereof,
857	857	date of sale and the name of the patient or caregiver to whom it was sold;
858	858	and
859	859	(5) comply with the packaging and labeling requirements of section
860	860	12, and amendments thereto.
861	861	(e) When verifying the validity of a medical cannabis certificate that
862	862	designates a caregiver, the caregiver and the patient shall both be
863	863	physically present at the time of verification and both shall provide the
864	864	required photo identification. All verified medical cannabis certificates
865	865	shall be maintained by the distribution hub either in physical or electronic
866	866	form.
867	867	(f) Each distribution hub shall take reasonable measures to prevent
868	868	the public disclosure of any information contained on a medical cannabis
869	869	certificate or photo identification, except as required by this act or court
870	870	order.
871	871	(g) (1) All sales of medical cannabis and medical cannabis products
872	872	shall require the patient or caregiver to order such medical cannabis or
873	873	medical cannabis products and complete payment prior to receiving such
874	874	medical cannabis or medical cannabis products at the distribution hub or
875	875	by delivery. Each patient or caregiver shall establish an account with a
876	876	distribution hub for the purpose of completing payment for medical
877	877	cannabis or medical cannabis products. A patient or caregiver account shall
878	878	be funded by a transfer of funds through a bank transfer, automated
879	879	clearing house transfer or debit transaction. Funds transferred to a patient
880	880	or caregiver account shall be nonrefundable.
881	881	(2) No medical cannabis or medical cannabis products shall be
882	882	purchased with cash or a credit card.
883	883	(3) Distribution hubs shall ensure that all patient and caregiver
884	884	financial account information is kept secure and confidential.
885	885	(h) No sale of medical cannabis or medical cannabis products shall
886	886	exceed the amount allowed under section 22, and amendments thereto.
887	887	(i) Each distribution hub shall take reasonable measures to prevent
888	888	diversion or theft of medical cannabis and medical cannabis products from
889	889	any distribution hub or vehicle used for delivery that is operated by such
890	890	distribution hub.
891	891	New Sec. 9. (a) A distribution hub may transport and deliver medical
892	892	cannabis and medical cannabis products from the premises of such
893	893	1
894	894	2
895	895	3
896	896	4
897	897	5
898	898	6
899	899	7
900	900	8
901	901	9
902	902	10
903	903	11
904	904	12
905	905	13
906	906	14
907	907	15
908	908	16
909	909	17
910	910	18
911	911	19
912	912	20
913	913	21
914	914	22
915	915	23
916	916	24
917	917	25
918	918	26
919	919	27
920	920	28
921	921	29
922	922	30
923	923	31
924	924	32
925	925	33
926	926	34
927	927	35
928	928	36
929	929	37
930	930	38
931	931	39
932	932	40
933	933	41
934	934	42
935	935	43 SB 555 12
936	936	distribution hub to patients and caregivers. The medical cannabis operator
937	937	or pharmacy shall conduct a criminal history background check on all
938	938	individuals who transport or deliver medical cannabis or medical cannabis
939	939	products on behalf of such distribution hub. No individual who has been
940	940	convicted of a felony shall transport or deliver medical cannabis or
941	941	medical cannabis products.
942	942	(b) All vehicles used for the transportation of medical cannabis or
943	943	medical cannabis products shall have GPS tracking, a dashboard camera
944	944	and a camera covering all areas containing medical cannabis or medical
945	945	cannabis products within such vehicle. Such vehicle cameras shall record
946	946	activity any time such vehicle is being loaded with medical cannabis or
947	947	medical cannabis products or is located outside the premises of a
948	948	distribution hub.
949	949	(c) A distribution hub may contract with one or more delivery service
950	950	providers for the purpose of delivering medical cannabis and medical
951	951	cannabis products to patients and caregivers. Such delivery service
952	952	providers shall comply with applicable provisions of this act relating to the
953	953	delivery of medical cannabis and medical cannabis products, vehicles used
954	954	for such deliveries and individuals making such deliveries. The
955	955	distribution hub shall be responsible for ensuring such compliance.
956	956	(d) A distribution hub may sell products that are reasonably necessary
957	957	for patients to consume medical cannabis and medical cannabis products
958	958	in accordance with this act. The sale of pipes, water pipes or other
959	959	paraphernalia utilized for the smoking of cannabis, tobacco or other
960	960	smokable products shall be prohibited.
961	961	New Sec. 10. Each distribution hub shall collaborate with the
962	962	secretary in the collection of patient data through voluntary surveys
963	963	completed by patients. Data collected via such surveys shall be collected
964	964	by distribution hubs and may be used by the secretary for the purpose of
965	965	studying medical cannabis. Such survey results shall be collected and
966	966	compiled in a manner that protects against disclosure of patient identities.
967	967	Distribution hubs shall provide patients and caregivers the option to
968	968	participate in such surveys at such times that the patient or caregiver is
969	969	receiving medical cannabis or medical cannabis products from the
970	970	distribution hub.
971	971	New Sec. 11. (a) On or before June 30, 2025, and each June 30
972	972	thereafter, each medical cannabis operator shall submit a report to the
973	973	secretary for each facility used for the cultivation or processing of medical
974	974	cannabis by such operator. Each report shall contain the following
975	975	information for the immediately preceding 12 months:
976	976	(1) The total amount of medical cannabis cultivated and harvested;
977	977	(2) the total amount of medical cannabis processed into medical
978	978	cannabis products;
979	979	1
980	980	2
981	981	3
982	982	4
983	983	5
984	984	6
985	985	7
986	986	8
987	987	9
988	988	10
989	989	11
990	990	12
991	991	13
992	992	14
993	993	15
994	994	16
995	995	17
996	996	18
997	997	19
998	998	20
999	999	21
1000	1000	22
1001	1001	23
1002	1002	24
1003	1003	25
1004	1004	26
1005	1005	27
1006	1006	28
1007	1007	29
1008	1008	30
1009	1009	31
1010	1010	32
1011	1011	33
1012	1012	34
1013	1013	35
1014	1014	36
1015	1015	37
1016	1016	38
1017	1017	39
1018	1018	40
1019	1019	41
1020	1020	42
1021	1021	43 SB 555 13
1022	1022	(3) a description of the cultivation and processing procedures used
1023	1023	and the relative effectiveness of such procedures;
1024	1024	(4) a description of the impact the requirements of this act had on the
1025	1025	business operations of the medical cannabis operator under the medical
1026	1026	cannabis pilot program; and
1027	1027	(5) any recommendations regarding any of the requirements of this
1028	1028	act that would improve the medical cannabis pilot program or any
1029	1029	subsequent medical cannabis program.
1030	1030	(b) On or before June 30, 2025, and each June 30 thereafter, each
1031	1031	distribution hub shall submit a report to the secretary. Each report shall
1032	1032	contain the following information for the immediately preceding 12
1033	1033	months:
1034	1034	(1) The total amount of medical cannabis and medical cannabis
1035	1035	products sold to patients and caregivers and the portion of such amount
1036	1036	that was provided in person at a distribution hub and that was delivered;
1037	1037	(2) a description of the operating procedures used in the storage,
1038	1038	transportation, sale and delivery of medical cannabis and medical cannabis
1039	1039	products to patients and caregivers;
1040	1040	(3) a description of the impact the requirements of this act had on the
1041	1041	business operations of the distribution hub under the medical cannabis
1042	1042	pilot program; and
1043	1043	(4) any recommendations regarding any of the requirements of this
1044	1044	act that would improve the medical cannabis pilot program or any
1045	1045	subsequent medical cannabis program.
1046	1046	New Sec. 12. (a) Only the following forms of medical cannabis may
1047	1047	be dispensed under the medical cannabis pilot program:
1048	1048	(1) Medical cannabis flower;
1049	1049	(2) pills or tablets;
1050	1050	(3) tinctures;
1051	1051	(4) patches; or
1052	1052	(5) ointments.
1053	1053	(b) The smoking, combustion or vaporization of medical cannabis or
1054	1054	medical cannabis products is prohibited. The inhalation of vapors released
1055	1055	by the non-combustive heating of cannabis flower shall not be considered
1056	1056	smoking or vaporization.
1057	1057	(c) Medical cannabis shall not contain a tetrahydrocannabinol content
1058	1058	in excess of 35%. Any medical cannabis having more than such amount of
1059	1059	THC shall be processed into medical cannabis products or destroyed.
1060	1060	(d) All medical cannabis and medical cannabis products sold to
1061	1061	patients and caregivers shall:
1062	1062	(1) Be contained in tamper-proof and child-resistant packaging; and
1063	1063	(2) have an attached label displaying:
1064	1064	(A) The patient's name, and, if applicable, the caregiver's name;
1065	1065	1
1066	1066	2
1067	1067	3
1068	1068	4
1069	1069	5
1070	1070	6
1071	1071	7
1072	1072	8
1073	1073	9
1074	1074	10
1075	1075	11
1076	1076	12
1077	1077	13
1078	1078	14
1079	1079	15
1080	1080	16
1081	1081	17
1082	1082	18
1083	1083	19
1084	1084	20
1085	1085	21
1086	1086	22
1087	1087	23
1088	1088	24
1089	1089	25
1090	1090	26
1091	1091	27
1092	1092	28
1093	1093	29
1094	1094	30
1095	1095	31
1096	1096	32
1097	1097	33
1098	1098	34
1099	1099	35
1100	1100	36
1101	1101	37
1102	1102	38
1103	1103	39
1104	1104	40
1105	1105	41
1106	1106	42
1107	1107	43 SB 555 14
1108	1108	(B) the date of purchase;
1109	1109	(C) the name and address of the medical cannabis operator that
1110	1110	produced the medical cannabis or medical cannabis product and the name,
1111	1111	address and phone number of the distribution hub that sold such medical
1112	1112	cannabis or medical cannabis product;
1113	1113	(D) the directions for use and the date on which the medical cannabis
1114	1114	or medical cannabis product was packaged;
1115	1115	(E) the tetrahydrocannabinol content contained in each serving if it is
1116	1116	a medical cannabis product, or as a percentage by weight if it is medical
1117	1117	cannabis; and
1118	1118	(F) a statement that reads "Medical cannabis use is not recommended
1119	1119	for women who are pregnant."; and
1120	1120	(G) a statement that reads "DO NOT OPEN THIS BAG WHILE IN
1121	1121	TRANSIT. It is illegal to possess medical cannabis or medical cannabis
1122	1122	products outside of this sealed bag while inside any motor vehicle,
1123	1123	watercraft or aircraft."
1124	1124	New Sec. 13. (a) No signage, including any advertisements for
1125	1125	medical cannabis or medical cannabis products, shall be visible from the
1126	1126	exterior of any facility of a medical cannabis operator used for cultivation
1127	1127	or processing.
1128	1128	(b) No medical cannabis operator shall advertise the sale, possession
1129	1129	or use of medical cannabis or medical cannabis products through
1130	1130	television, radio, billboards, portable signage or other broadcast media,
1131	1131	except advertisements for medical cannabis or medical cannabis products
1132	1132	may be published via the internet. Advertisements permitted under this
1133	1133	section, including any advertisements published by a distribution hub,
1134	1134	shall not contain any:
1135	1135	(1) Representation or suggestion that any medical cannabis or
1136	1136	medical cannabis product is an effective treatment for any illness, disease,
1137	1137	adverse condition or malady, whether such illness, disease, condition or
1138	1138	malady is a qualifying medical condition;
1139	1139	(2) representation or suggestion that a medical cannabis brand or
1140	1140	product is more effective or safer than other drugs or treatments, including
1141	1141	other medical cannabis brands or products;
1142	1142	(3) statement that is false or misleading or is otherwise in violation of
1143	1143	the Kansas consumer protection act;
1144	1144	(4) statement that falsely disparages a competitor's products;
1145	1145	(5) statement, design, representation, picture or illustration that:
1146	1146	(A) Is obscene or indecent;
1147	1147	(B) encourages or represents the use of cannabis or cannabis products
1148	1148	for any purpose other than for treating a qualifying medical condition; or
1149	1149	(C) portrays anyone under 21 years of age;
1150	1150	(6) offer of a prize or award to any person; or
1151	1151	1
1152	1152	2
1153	1153	3
1154	1154	4
1155	1155	5
1156	1156	6
1157	1157	7
1158	1158	8
1159	1159	9
1160	1160	10
1161	1161	11
1162	1162	12
1163	1163	13
1164	1164	14
1165	1165	15
1166	1166	16
1167	1167	17
1168	1168	18
1169	1169	19
1170	1170	20
1171	1171	21
1172	1172	22
1173	1173	23
1174	1174	24
1175	1175	25
1176	1176	26
1177	1177	27
1178	1178	28
1179	1179	29
1180	1180	30
1181	1181	31
1182	1182	32
1183	1183	33
1184	1184	34
1185	1185	35
1186	1186	36
1187	1187	37
1188	1188	38
1189	1189	39
1190	1190	40
1191	1191	41
1192	1192	42
1193	1193	43 SB 555 15
1194	1194	(7) statement that indicates or implies that the product or entity in the
1195	1195	advertisement has been approved or endorsed by any agency, officer or
1196	1196	agent of the state of Kansas or any person or entity associated with the
1197	1197	state.
1198	1198	(c) No medical cannabis operator or pharmacy shall engage, contract
1199	1199	or otherwise enter into any agreement with any person for the purpose of
1200	1200	advertising medical cannabis or medical cannabis products in any manner
1201	1201	prohibited by this section.
1202	1202	New Sec. 14. (a) Each medical cannabis operator shall monitor all
1203	1203	medical cannabis and medical cannabis products that become part of such
1204	1204	operator's inventory from the seed source through the cultivation, testing,
1205	1205	processing, distribution and dispensing of such medical cannabis or
1206	1206	medical cannabis product utilizing a tracking system as agreed to by the
1207	1207	secretary. The same tracking system shall be utilized by all operators. Each
1208	1208	distribution hub operated by a pharmacy shall participate in the tracking
1209	1209	system through coordination with the medical cannabis operators that sell
1210	1210	medical cannabis and medical cannabis products to such distribution hub.
1211	1211	(b) Upon request, a medical cannabis operator shall make all tracking
1212	1212	information available to the secretary, the state contracted laboratory and
1213	1213	any law enforcement agency, its officers and agents.
1214	1214	New Sec. 15. (a) No distribution hub shall be located within 1,000
1215	1215	feet of the boundaries of a parcel of real estate having situated on it a
1216	1216	school, public library or public park.
1217	1217	(b) No cultivation or processing facility shall be located within 500
1218	1218	feet of the boundaries of a parcel of real estate having situated on it a
1219	1219	school, public library or public park. A cultivator or processor facility shall
1220	1220	be located on real property that is classified as an industrial zone.
1221	1221	(c) It shall not be a violation of this section if a distribution hub or
1222	1222	cultivation or processing facility existed at a location prior to the
1223	1223	establishment of a school, public library or public park that is located on
1224	1224	real estate that is within minimum required distance of such facility as
1225	1225	specified in this section.
1226	1226	(d) This section shall not apply to research related to cannabis
1227	1227	conducted at a postsecondary educational institution, academic medical
1228	1228	center or private research and development organization as part of a
1229	1229	research protocol approved by an institutional review board or equivalent
1230	1230	entity.
1231	1231	(e) All distribution hubs and cultivator and processing facilities shall
1232	1232	comply with all applicable zoning and building regulations.
1233	1233	(f) As used in this section:
1234	1234	(1) "Public library" means any library established pursuant to article
1235	1235	12 of chapter 12 of the Kansas Statutes Annotated, and amendments
1236	1236	thereto, and any other library that serves the general public and is funded
1237	1237	1
1238	1238	2
1239	1239	3
1240	1240	4
1241	1241	5
1242	1242	6
1243	1243	7
1244	1244	8
1245	1245	9
1246	1246	10
1247	1247	11
1248	1248	12
1249	1249	13
1250	1250	14
1251	1251	15
1252	1252	16
1253	1253	17
1254	1254	18
1255	1255	19
1256	1256	20
1257	1257	21
1258	1258	22
1259	1259	23
1260	1260	24
1261	1261	25
1262	1262	26
1263	1263	27
1264	1264	28
1265	1265	29
1266	1266	30
1267	1267	31
1268	1268	32
1269	1269	33
1270	1270	34
1271	1271	35
1272	1272	36
1273	1273	37
1274	1274	38
1275	1275	39
1276	1276	40
1277	1277	41
1278	1278	42
1279	1279	43 SB 555 16
1280	1280	in whole, or in part, from moneys derived from tax levies;
1281	1281	(2) "public park" means any park or other outdoor recreational area or
1282	1282	facility, including, but not limited to, parks, open spaces, trails, swimming
1283	1283	pools, playgrounds and playing courts and fields established by the state or
1284	1284	any political subdivision thereof; and
1285	1285	(3) "school" means any public or private preschool, elementary,
1286	1286	middle or high school or other attendance center for kindergarten or any of
1287	1287	the grades one through 12.
1288	1288	New Sec. 16. (a) The premises for any distribution hub or cultivation
1289	1289	or processing facility shall be equipped with security equipment and
1290	1290	measures to prevent unauthorized access and the theft, diversion or
1291	1291	inversion of medical cannabis or medial cannabis products. As a condition
1292	1292	of each contract, such security equipment and measures shall include:
1293	1293	(1) Exterior lighting sufficient to illuminate all entrances to such
1294	1294	premises;
1295	1295	(2) electronic video monitoring in accordance with subsection (c);
1296	1296	(3) except for areas designated for patient and caregiver access,
1297	1297	controlled access to all areas within the premises by means of electronic
1298	1298	card access systems, biometric identification systems or similar systems
1299	1299	that:
1300	1300	(A) Provide for the automatic locking of all external access doors in
1301	1301	the event of power loss; and
1302	1302	(B) records access information by date, time and identity of the
1303	1303	individual accessing such areas and retains such information for at least
1304	1304	one year;
1305	1305	(4) secured windows, if any, to prevent opening or other access to
1306	1306	such areas via such windows; and
1307	1307	(5) alarm systems that provide:
1308	1308	(A) Immediate, automatic notification of local law enforcement
1309	1309	agencies of any unauthorized breach of the security of the premises; and
1310	1310	(B) for distribution hubs, manual, silent alarms in each area
1311	1311	designated for patient and caregiver access that provides for the
1312	1312	immediate, automatic notification of local law enforcement agencies.
1313	1313	(b) Any electronic video monitoring system shall:
1314	1314	(1) Include coverage of:
1315	1315	(A) The interior and exterior of all entrances to the premises;
1316	1316	(B) any area designated for parking on the premises;
1317	1317	(C) each area designated for patient and caregiver access;
1318	1318	(D) all vaults, safes or storage areas containing medical cannabis or
1319	1319	medical cannabis products; and
1320	1320	(E) all areas where medical cannabis and medical cannabis products
1321	1321	are cultivated, processed, prepared for sale or delivery or disposed of as
1322	1322	waste;
1323	1323	1
1324	1324	2
1325	1325	3
1326	1326	4
1327	1327	5
1328	1328	6
1329	1329	7
1330	1330	8
1331	1331	9
1332	1332	10
1333	1333	11
1334	1334	12
1335	1335	13
1336	1336	14
1337	1337	15
1338	1338	16
1339	1339	17
1340	1340	18
1341	1341	19
1342	1342	20
1343	1343	21
1344	1344	22
1345	1345	23
1346	1346	24
1347	1347	25
1348	1348	26
1349	1349	27
1350	1350	28
1351	1351	29
1352	1352	30
1353	1353	31
1354	1354	32
1355	1355	33
1356	1356	34
1357	1357	35
1358	1358	36
1359	1359	37
1360	1360	38
1361	1361	39
1362	1362	40
1363	1363	41
1364	1364	42
1365	1365	43 SB 555 17
1366	1366	(2) store all video recordings for at least 90 days in a secure location
1367	1367	on or off the premises or through a secure service or network that provides
1368	1368	on-demand access to such recordings. All such recordings shall be made
1369	1369	available upon request to the secretary and any law enforcement agency,
1370	1370	its officers and agents; and
1371	1371	(3) accurately display the date and time of all recorded events in a
1372	1372	manner that does not obstruct the recorded view.
1373	1373	(c) Each medical cannabis operator and pharmacy shall establish
1374	1374	policies and procedures for the security of premises of each facility
1375	1375	operated by such operator. Such policies and procedures shall include:
1376	1376	(1) Controlling access to all areas that are not designated for patient
1377	1377	and caregiver access;
1378	1378	(2) posting signage stating that all transactions are cashless and that
1379	1379	no money is kept on premises;
1380	1380	(3) use of electronic video monitoring systems;
1381	1381	(4) use of alarm systems, including the use of manual, silent alarms
1382	1382	for distribution hubs; and
1383	1383	(5) communication with local law enforcement agencies regarding
1384	1384	unauthorized security breaches and the employment and identity of any
1385	1385	armed security personnel by the licensee.
1386	1386	(d) Each medical cannabis operator and pharmacy shall ensure that all
1387	1387	employees have completed training in security equipment and measures,
1388	1388	including:
1389	1389	(1) Prevention of theft, diversion and inversion of medical cannabis
1390	1390	and medical cannabis products;
1391	1391	(2) emergency response procedures;
1392	1392	(3) appropriate use of force; and
1393	1393	(4) controlling access to areas that are not designated for patient and
1394	1394	caregiver access.
1395	1395	(e) Except as provided in subsection (b)(2), each medical cannabis
1396	1396	operator and pharmacy shall retain all documents related to security
1397	1397	equipment and measures and any other documents related to the operations
1398	1398	of the facility for a period of two years. Such documents shall be made
1399	1399	available upon request to the secretary.
1400	1400	(f) Each medical cannabis operator and pharmacy shall ensure that all
1401	1401	medical cannabis waste is destroyed or otherwise disposed of in a manner
1402	1402	that prevents access to such waste by any person not authorized by such
1403	1403	operator or pharmacy.
1404	1404	(g) For distribution hubs and cultivation and processing facilities
1405	1405	whose physical structures are in existence on July 1, 2024, the
1406	1406	requirements of this section shall be satisfied on or before September 1,
1407	1407	2024. For all other facilities, the requirements of this section shall be
1408	1408	satisfied prior to commencement of operations.
1409	1409	1
1410	1410	2
1411	1411	3
1412	1412	4
1413	1413	5
1414	1414	6
1415	1415	7
1416	1416	8
1417	1417	9
1418	1418	10
1419	1419	11
1420	1420	12
1421	1421	13
1422	1422	14
1423	1423	15
1424	1424	16
1425	1425	17
1426	1426	18
1427	1427	19
1428	1428	20
1429	1429	21
1430	1430	22
1431	1431	23
1432	1432	24
1433	1433	25
1434	1434	26
1435	1435	27
1436	1436	28
1437	1437	29
1438	1438	30
1439	1439	31
1440	1440	32
1441	1441	33
1442	1442	34
1443	1443	35
1444	1444	36
1445	1445	37
1446	1446	38
1447	1447	39
1448	1448	40
1449	1449	41
1450	1450	42
1451	1451	43 SB 555 18
1452	1452	New Sec. 17. (a) All individuals holding an ownership interest in or
1453	1453	actively engaging in the operations of a medical cannabis operator or a
1454	1454	distribution hub operated by a pharmacy shall not have been convicted of a
1455	1455	felony. Each medical cannabis operator and pharmacy shall take
1456	1456	reasonable measures to ensure compliance with this section, including, but
1457	1457	not limited to, conducting criminal history background checks. Each
1458	1458	operator and pharmacy shall maintain an employee roster and log that
1459	1459	includes the identity, address, contact information and criminal history
1460	1460	background check information for each employed individual.
1461	1461	(b) All directors, managers, officers and any other employee of a
1462	1462	medical cannabis operator or pharmacy shall be considered to be actively
1463	1463	engaged in the operations of such operator or pharmacy. Independent
1464	1464	contractors shall not be considered to be actively engaged in operations if
1465	1465	such contractors are not directly engaged in the cultivation, processing or
1466	1466	sale of medical cannabis or medical cannabis products.
1467	1467	New Sec. 18. (a) A financial institution that provides financial
1468	1468	services to any medical cannabis operator, pharmacy or state contracted
1469	1469	laboratory shall be exempt from any criminal law of this state, an element
1470	1470	of which may be proven beyond a reasonable doubt that a person provides
1471	1471	financial services to a person who possesses, delivers or manufactures
1472	1472	medical cannabis or medical cannabis products, including any of the
1473	1473	offenses specified in article 57 of chapter 21 of the Kansas Statutes
1474	1474	Annotated, and amendments thereto, or any attempt, conspiracy or
1475	1475	solicitation specified in article 53 of chapter 21 of the Kansas Statutes
1476	1476	Annotated, and amendments thereto, if the medical cannabis operator,
1477	1477	pharmacy or state contracted laboratory is in compliance with the
1478	1478	provisions of this act and all applicable tax laws of this state.
1479	1479	(b) Upon the request of a financial institution, the secretary, medical
1480	1480	cannabis operator, pharmacy or state contracted laboratory shall provide to
1481	1481	the financial institution the following information:
1482	1482	(1) Whether a person with whom the financial institution is seeking to
1483	1483	do business has a contract with the secretary to operate as a medical
1484	1484	cannabis operator, operate a distribution hub or a state contracted
1485	1485	laboratory;
1486	1486	(2) the name of any other business or individual affiliated with such
1487	1487	person; and
1488	1488	(3) information relating to sales and volume of product sold by such
1489	1489	person, if applicable.
1490	1490	(c) Information received by a financial institution under subsection
1491	1491	(b) is confidential. Except as otherwise permitted by any other state or
1492	1492	federal law, a financial institution shall not make the information available
1493	1493	to any person other than the customer to whom the information applies and
1494	1494	any trustee, conservator, guardian, personal representative or agent of such
1495	1495	1
1496	1496	2
1497	1497	3
1498	1498	4
1499	1499	5
1500	1500	6
1501	1501	7
1502	1502	8
1503	1503	9
1504	1504	10
1505	1505	11
1506	1506	12
1507	1507	13
1508	1508	14
1509	1509	15
1510	1510	16
1511	1511	17
1512	1512	18
1513	1513	19
1514	1514	20
1515	1515	21
1516	1516	22
1517	1517	23
1518	1518	24
1519	1519	25
1520	1520	26
1521	1521	27
1522	1522	28
1523	1523	29
1524	1524	30
1525	1525	31
1526	1526	32
1527	1527	33
1528	1528	34
1529	1529	35
1530	1530	36
1531	1531	37
1532	1532	38
1533	1533	39
1534	1534	40
1535	1535	41
1536	1536	42
1537	1537	43 SB 555 19
1538	1538	customer.
1539	1539	(d) As used in this section:
1540	1540	(1) "Financial institution" means any bank, trust company, savings
1541	1541	bank, credit union or savings and loan association or any other financial
1542	1542	institution regulated by the state of Kansas, any agency of the United
1543	1543	States or other state with an office in Kansas that complies with the
1544	1544	requirements of the financial crimes enforcement network of the United
1545	1545	States treasury department; and
1546	1546	(2) "financial services" means services that a financial institution is
1547	1547	authorized to provide under chapter 9 or article 22 of chapter 17 of the
1548	1548	Kansas Statutes Annotated, and amendments thereto, as applicable.
1549	1549	New Sec. 19. The secretary shall designate at least five physicians for
1550	1550	the purpose of issuing medical cannabis certificates to patients. Designated
1551	1551	physicians may issue medical cannabis certificates to patients suffering
1552	1552	from a qualifying medical condition when such patient's primary care
1553	1553	physician declines to issue such certificate for any reason. To the extent
1554	1554	practicable, the secretary shall designate physicians from different parts of
1555	1555	the state to ensure patients are able to have reasonable geographic access
1556	1556	to such physicians.
1557	1557	New Sec. 20. (a) It shall be unlawful for:
1558	1558	(1) A patient to purchase, possess or consume medical cannabis and
1559	1559	medical cannabis products unless such patient holds a valid medical
1560	1560	cannabis certificate; and
1561	1561	(2) any other individual to purchase or possess medical cannabis and
1562	1562	medical cannabis products on behalf of a patient or to assist such patient in
1563	1563	the consumption of medical cannabis and medical cannabis products
1564	1564	unless such individual is designated as such patient's caregiver on a valid
1565	1565	medical cannabis certificate and holds a copy of such valid medical
1566	1566	cannabis certificate.
1567	1567	(b) Patients and caregivers shall be at least 21 years of age.
1568	1568	(c) A physician may issue a medical cannabis certificate if the:
1569	1569	(1) Physician is the patient's primary care physician or a physician
1570	1570	designated by the secretary pursuant to section 19, and amendments
1571	1571	thereto, and determined that the patient suffers from one or more
1572	1572	qualifying medical conditions;
1573	1573	(2) physician has reviewed the patient's medical records and has
1574	1574	reasonably determined that such patient is not currently or likely to be
1575	1575	diagnosed with schizophrenia after taking into consideration such patient's
1576	1576	family history of schizophrenia;
1577	1577	(3) physician has informed the patient of the risks and benefits of
1578	1578	medical cannabis use as it pertains to the patient's qualifying medical
1579	1579	condition and medical history;
1580	1580	(4) physician reasonably believes that the benefits of medical
1581	1581	1
1582	1582	2
1583	1583	3
1584	1584	4
1585	1585	5
1586	1586	6
1587	1587	7
1588	1588	8
1589	1589	9
1590	1590	10
1591	1591	11
1592	1592	12
1593	1593	13
1594	1594	14
1595	1595	15
1596	1596	16
1597	1597	17
1598	1598	18
1599	1599	19
1600	1600	20
1601	1601	21
1602	1602	22
1603	1603	23
1604	1604	24
1605	1605	25
1606	1606	26
1607	1607	27
1608	1608	28
1609	1609	29
1610	1610	30
1611	1611	31
1612	1612	32
1613	1613	33
1614	1614	34
1615	1615	35
1616	1616	36
1617	1617	37
1618	1618	38
1619	1619	39
1620	1620	40
1621	1621	41
1622	1622	42
1623	1623	43 SB 555 20
1624	1624	cannabis use by the patient outweigh its risks after considering the patient's
1625	1625	history of substance abuse and the potential detrimental effects of medical
1626	1626	cannabis use on the patient's health; and
1627	1627	(5) caregiver, if designated, is present at the time the medical
1628	1628	cannabis certificate is issued and the physician reasonably believes that the
1629	1629	patient would not be capable or would have significant difficulty in
1630	1630	purchasing, possessing or consuming medical cannabis or medical
1631	1631	cannabis products without the assistance of the caregiver.
1632	1632	(d) A medical cannabis certificate shall be in writing, signed by the
1633	1633	physician, patient and caregiver, if designated, and include the following:
1634	1634	(1) The name, address and phone number of the patient and any
1635	1635	caregiver, if designated;
1636	1636	(2) the name, address and phone number of the physician issuing the
1637	1637	certificate;
1638	1638	(3) the date such certificate was issued;
1639	1639	(4) a statement from the physician certifying that:
1640	1640	(A) The physician is either the patient's primary care physician or a
1641	1641	designated physician pursuant to section 19, and amendments thereto,
1642	1642	authorized to issue medical cannabis certificates;
1643	1643	(B) the qualifying medical condition the patient suffers from; and
1644	1644	(C) the physician recommends the patient treat the symptoms of the
1645	1645	qualifying medical condition by consumption of medical cannabis and
1646	1646	medical cannabis products;
1647	1647	(5) a certification by the patient and caregiver, if designated, that
1648	1648	neither the patient nor caregiver has knowingly misstated, misled, lied to
1649	1649	or otherwise provided false information to the physician that is relevant to
1650	1650	the diagnosis of the qualifying medical condition or the issuance of the
1651	1651	medical cannabis certificate;
1652	1652	(6) a certification by the physician, patient and caregiver, if
1653	1653	designated, that all of the information contained in the medical cannabis
1654	1654	certificate is true and accurate to the best of their belief;
1655	1655	(7) the name and address of the designated distribution hub for the
1656	1656	purchase of medical cannabis and medical cannabis products by the patient
1657	1657	and caregiver, if designated;
1658	1658	(8) an authorization, including a waiver of applicable healthcare
1659	1659	privacy rights, by the patient allowing the physician to communicate with
1660	1660	the designated distribution hub and discuss any of the information
1661	1661	contained in the medical cannabis certificate;
1662	1662	(9) the identification, if any, of one caregiver to assist the patient in
1663	1663	the purchase, possession and consumption of medical cannabis and
1664	1664	medical cannabis products; and
1665	1665	(10) a certification by the caregiver, if designated, that such caregiver
1666	1666	has not been convicted of any drug-related felony, whether such conviction
1667	1667	1
1668	1668	2
1669	1669	3
1670	1670	4
1671	1671	5
1672	1672	6
1673	1673	7
1674	1674	8
1675	1675	9
1676	1676	10
1677	1677	11
1678	1678	12
1679	1679	13
1680	1680	14
1681	1681	15
1682	1682	16
1683	1683	17
1684	1684	18
1685	1685	19
1686	1686	20
1687	1687	21
1688	1688	22
1689	1689	23
1690	1690	24
1691	1691	25
1692	1692	26
1693	1693	27
1694	1694	28
1695	1695	29
1696	1696	30
1697	1697	31
1698	1698	32
1699	1699	33
1700	1700	34
1701	1701	35
1702	1702	36
1703	1703	37
1704	1704	38
1705	1705	39
1706	1706	40
1707	1707	41
1708	1708	42
1709	1709	43 SB 555 21
1710	1710	has been expunged.
1711	1711	(e) The physician issuing the medical cannabis certificate shall
1712	1712	transmit a copy of such certificate sent to the designated distribution hub.
1713	1713	Patients and caregivers shall only purchase medical cannabis and medical
1714	1714	cannabis products from the designated distribution hub, except that
1715	1715	patients and caregivers may purchase medical cannabis and medical
1716	1716	cannabis products from an alternate distribution hub if:
1717	1717	(1) The designated distribution hub transmits a copy of the patient's
1718	1718	medical cannabis certificate to such alternate distribution hub;
1719	1719	(2) the designated distribution hub notifies such alternate distribution
1720	1720	hub of the amount of medical cannabis and medical cannabis products
1721	1721	purchased by the patient or caregiver in the 30 days prior to transmitting
1722	1722	such patient's medical cannabis certificate;
1723	1723	(3) the patient or caregiver does not purchase in the aggregate an
1724	1724	amount of medical cannabis and medical cannabis products that exceeds
1725	1725	the amount specified in section 22, and amendments thereto, from all
1726	1726	distribution hubs; and
1727	1727	(4) such alternate distribution hub notifies the designated distribution
1728	1728	hub of the amount of medical cannabis and medical cannabis products
1729	1729	purchased by the patient or caregiver.
1730	1730	(f) A medical cannabis certificate shall be valid for a period of one
1731	1731	year from the date of issuance.
1732	1732	(g) The physician issuing the medical cannabis certificate for a
1733	1733	patient shall not also serve as such patient's designated caregiver.
1734	1734	(h) A physician who issues a medical cannabis certificate shall be
1735	1735	exempt from liability for any injuries or other damages arising from or
1736	1736	otherwise related to the purchase, possession or consumption of medical
1737	1737	cannabis or medical cannabis products by the patient or caregiver, if any,
1738	1738	named on such certificate if, at the time such certificate is issued, such
1739	1739	physician:
1740	1740	(1) Has reviewed such patient's medical records and reasonably
1741	1741	believes that such patient is not pregnant and is not likely to suffer from
1742	1742	schizophrenia; and
1743	1743	(2) reasonably believes that such patient suffers from a qualifying
1744	1744	medical condition based on the information provided by such patient and
1745	1745	such information is supported by such patient's medical records.
1746	1746	(i) Providing false information to a physician for the purpose of
1747	1747	obtaining a medical cannabis certificate shall not be a confidential
1748	1748	communication between such physician and patient and neither the patient
1749	1749	or the caregiver, if designated, shall have a privilege in any prosecution for
1750	1750	unlawfully possessing a controlled substance under K.S.A. 21-5706, and
1751	1751	amendments thereto, or unlawfully possessing drug paraphernalia under
1752	1752	K.S.A. 21-5709, and amendments thereto.
1753	1753	1
1754	1754	2
1755	1755	3
1756	1756	4
1757	1757	5
1758	1758	6
1759	1759	7
1760	1760	8
1761	1761	9
1762	1762	10
1763	1763	11
1764	1764	12
1765	1765	13
1766	1766	14
1767	1767	15
1768	1768	16
1769	1769	17
1770	1770	18
1771	1771	19
1772	1772	20
1773	1773	21
1774	1774	22
1775	1775	23
1776	1776	24
1777	1777	25
1778	1778	26
1779	1779	27
1780	1780	28
1781	1781	29
1782	1782	30
1783	1783	31
1784	1784	32
1785	1785	33
1786	1786	34
1787	1787	35
1788	1788	36
1789	1789	37
1790	1790	38
1791	1791	39
1792	1792	40
1793	1793	41
1794	1794	42
1795	1795	43 SB 555 22
1796	1796	(j) Nothing in this act shall be construed to prohibit a person who is
1797	1797	designated as a caregiver on a valid medical cannabis certificate from
1798	1798	being issued a medical cannabis certificate as a patient.
1799	1799	New Sec. 21. Law enforcement agencies may obtain verification of a
1800	1800	medical cannabis certificate from a patient's physician or a distribution hub
1801	1801	when necessary to verify that a patient or caregiver is in compliance with
1802	1802	this act. Each patient and caregiver shall promptly deliver such patient's
1803	1803	medical cannabis certificate upon demand of any officer of a court of
1804	1804	competent jurisdiction or any law enforcement officer when the certificate
1805	1805	is in such patient's or caregiver's immediate possession at the time of the
1806	1806	demand.
1807	1807	New Sec. 22. (a) A patient who holds a valid medical cannabis
1808	1808	certificate may:
1809	1809	(1) Use or consume medical cannabis and medical cannabis products;
1810	1810	(2) subject to subsection (b), purchase and possess medical cannabis
1811	1811	and medical cannabis products; and
1812	1812	(3) purchase and possess any paraphernalia or accessories used to
1813	1813	administer or consume medical cannabis and medical cannabis products.
1814	1814	(b) A patient shall not purchase medical cannabis or medical cannabis
1815	1815	products in an amount that exceeds in the aggregate 200 grams of
1816	1816	unprocessed medical cannabis flower or 3.47 grams of
1817	1817	tetrahydrocannabinol contained in any medical cannabis product during
1818	1818	any 30-day period of time.
1819	1819	(c) Caregivers who hold a valid medical cannabis certificate on which
1820	1820	such individual is the designated caregiver may purchase and possess
1821	1821	medical cannabis, medical cannabis products, paraphernalia and
1822	1822	accessories used to administer or consume medical cannabis and medical
1823	1823	cannabis products on behalf of the patient named on the medical cannabis
1824	1824	certificate, and may reasonably assist such patient with using or
1825	1825	consuming medical cannabis and medical cannabis products. The
1826	1826	provisions of subsection (b) shall apply to the purchase of medical
1827	1827	cannabis and medical cannabis products by a caregiver. No other use or
1828	1828	consumption of any medical cannabis or medical cannabis products
1829	1829	purchased and possessed by a caregiver on behalf of a patient shall be
1830	1830	permitted.
1831	1831	(d) Nothing in this section shall be construed to authorize a patient to
1832	1832	operate a motor vehicle, watercraft or aircraft while under the influence of
1833	1833	medical cannabis or medical cannabis products. No patient or caregiver
1834	1834	shall possess medical cannabis or medical cannabis products while
1835	1835	operating or traveling in any motor vehicle, watercraft or aircraft unless
1836	1836	such medical cannabis or medical cannabis products are contained in the
1837	1837	original, sealed packaging obtained from the distribution hub. Any medical
1838	1838	cannabis or medical cannabis products in a motor vehicle, watercraft or
1839	1839	1
1840	1840	2
1841	1841	3
1842	1842	4
1843	1843	5
1844	1844	6
1845	1845	7
1846	1846	8
1847	1847	9
1848	1848	10
1849	1849	11
1850	1850	12
1851	1851	13
1852	1852	14
1853	1853	15
1854	1854	16
1855	1855	17
1856	1856	18
1857	1857	19
1858	1858	20
1859	1859	21
1860	1860	22
1861	1861	23
1862	1862	24
1863	1863	25
1864	1864	26
1865	1865	27
1866	1866	28
1867	1867	29
1868	1868	30
1869	1869	31
1870	1870	32
1871	1871	33
1872	1872	34
1873	1873	35
1874	1874	36
1875	1875	37
1876	1876	38
1877	1877	39
1878	1878	40
1879	1879	41
1880	1880	42
1881	1881	43 SB 555 23
1882	1882	aircraft that are not contained in the original, sealed packaging shall be
1883	1883	considered unlawful possession under this act, and neither the patient or
1884	1884	the caregiver, if designated, shall have a privilege in any prosecution for
1885	1885	unlawfully possessing a controlled substance under K.S.A. 21-5706, and
1886	1886	amendments thereto, or unlawfully possessing drug paraphernalia under
1887	1887	K.S.A. 21-5709, and amendments thereto.
1888	1888	New Sec. 23. Nothing in this act authorizes the secretary to oversee
1889	1889	or limit research conducted at a postsecondary educational institution,
1890	1890	academic medical center or private research and development organization
1891	1891	that is related to cannabis and is approved by an agency, board, center,
1892	1892	department or institute of the United States government, including any of
1893	1893	the following:
1894	1894	(a) The agency for health care research and quality;
1895	1895	(b) the national institutes of health;
1896	1896	(c) the national academy of sciences;
1897	1897	(d) the centers for medicare and medicaid services;
1898	1898	(e) the United States department of defense;
1899	1899	(f) the centers for disease control and prevention;
1900	1900	(g) the United States department of veterans affairs;
1901	1901	(h) the drug enforcement administration;
1902	1902	(i) the food and drug administration; and
1903	1903	(j) any board recognized by the national institutes of health for the
1904	1904	purpose of evaluating the medical value of healthcare services.
1905	1905	New Sec. 24. No provisions of the medical cannabis pilot program
1906	1906	act shall be construed to:
1907	1907	(a) Require an employer to permit or accommodate the use,
1908	1908	consumption, possession, transfer, display, distribution, transportation, sale
1909	1909	or growing of cannabis or any conduct otherwise allowed by this act in any
1910	1910	workplace or on the employer's property;
1911	1911	(b) prohibit a person, employer, corporation or any other entity that
1912	1912	occupies, owns or controls a property from prohibiting or otherwise
1913	1913	regulating the use, consumption, possession, transfer, display, distribution,
1914	1914	transportation, sale or growing of cannabis on such property;
1915	1915	(c) require any government medical assistance program, a private
1916	1916	health insurer or a workers compensation carrier or self-insured employer
1917	1917	providing workers compensation benefits to reimburse a person for costs
1918	1918	associated with the use of medical cannabis;
1919	1919	(d) affect the ability of an employer to implement policies to promote
1920	1920	workplace health and safety by restricting the use of cannabis by
1921	1921	employees;
1922	1922	(e) prohibit an employer from:
1923	1923	(1) Establishing and enforcing a drug testing policy, drug-free
1924	1924	workplace policy or zero-tolerance drug policy;
1925	1925	1
1926	1926	2
1927	1927	3
1928	1928	4
1929	1929	5
1930	1930	6
1931	1931	7
1932	1932	8
1933	1933	9
1934	1934	10
1935	1935	11
1936	1936	12
1937	1937	13
1938	1938	14
1939	1939	15
1940	1940	16
1941	1941	17
1942	1942	18
1943	1943	19
1944	1944	20
1945	1945	21
1946	1946	22
1947	1947	23
1948	1948	24
1949	1949	25
1950	1950	26
1951	1951	27
1952	1952	28
1953	1953	29
1954	1954	30
1955	1955	31
1956	1956	32
1957	1957	33
1958	1958	34
1959	1959	35
1960	1960	36
1961	1961	37
1962	1962	38
1963	1963	39
1964	1964	40
1965	1965	41
1966	1966	42
1967	1967	43 SB 555 24
1968	1968	(2) disciplining an employee for a violation of a workplace drug
1969	1969	policy or for working while under the influence of cannabis; or
1970	1970	(3) including a provision in any contract that prohibits the use of
1971	1971	cannabis;
1972	1972	(f) prevent an employer from, because of a person's violation of a
1973	1973	workplace drug policy or because that person was working while under the
1974	1974	influence of cannabis:
1975	1975	(1) Refusing to hire a person;
1976	1976	(2) discharging a person;
1977	1977	(3) disciplining a person; or
1978	1978	(4) otherwise taking an adverse employment action against a person
1979	1979	with respect to hiring decisions, tenure, terms, conditions or privileges of
1980	1980	employment; or
1981	1981	(g) permit the possession or use of medical cannabis by any person
1982	1982	detained in a correctional institution, as defined in K.S.A. 21-5914, and
1983	1983	amendments thereto, or committed to a care and treatment facility, as
1984	1984	defined in K.S.A. 21-5914, and amendments thereto.
1985	1985	New Sec. 25. On or before January 15 of each year, the secretary
1986	1986	shall prepare and submit a report to the governor and the legislature on the
1987	1987	medical cannabis pilot program. Each report shall contain:
1988	1988	(a) The information submitted by each medical cannabis operator in
1989	1989	the reports required pursuant to section 11, and amendments thereto;
1990	1990	(b) a description by the secretary of the relative success of policies,
1991	1991	procedures, standards and requirements imposed under the medical
1992	1992	cannabis pilot program; and
1993	1993	(c) any recommendations from the secretary that would help make the
1994	1994	medical cannabis pilot program and any subsequent cannabis-related
1995	1995	program successful.
1996	1996	New Sec. 26. The provisions of the medical cannabis pilot program
1997	1997	act are declared to be severable. If any part or provision of the medical
1998	1998	cannabis pilot program act is held to be void, invalid or unconstitutional,
1999	1999	such part or provision shall not affect or impair any of the remaining parts
2000	2000	or provisions of the medical cannabis pilot program act, and any such
2001	2001	remaining provisions shall continue in full force and effect.
2002	2002	New Sec. 27. The provisions of the medical cannabis pilot program
2003	2003	act, sections 1 through 27, and amendments thereto, shall expire on July 1,
2004	2004	2029.
2005	2005	New Sec. 28. (a) It shall be unlawful to store or otherwise leave
2006	2006	medical cannabis or a medical cannabis product where it is readily
2007	2007	accessible to a person under 21 years of age. Such conduct shall be
2008	2008	unlawful with no requirement of a culpable mental state.
2009	2009	(b) Violation of this section is a class A person misdemeanor.
2010	2010	(c) As used in this section:
2011	2011	1
2012	2012	2
2013	2013	3
2014	2014	4
2015	2015	5
2016	2016	6
2017	2017	7
2018	2018	8
2019	2019	9
2020	2020	10
2021	2021	11
2022	2022	12
2023	2023	13
2024	2024	14
2025	2025	15
2026	2026	16
2027	2027	17
2028	2028	18
2029	2029	19
2030	2030	20
2031	2031	21
2032	2032	22
2033	2033	23
2034	2034	24
2035	2035	25
2036	2036	26
2037	2037	27
2038	2038	28
2039	2039	29
2040	2040	30
2041	2041	31
2042	2042	32
2043	2043	33
2044	2044	34
2045	2045	35
2046	2046	36
2047	2047	37
2048	2048	38
2049	2049	39
2050	2050	40
2051	2051	41
2052	2052	42
2053	2053	43 SB 555 25
2054	2054	(1) "Medical cannabis" and "medical cannabis product" mean the
2055	2055	same as such terms are defined in section 2, and amendments thereto; and
2056	2056	(2) "readily accessible" means the medical cannabis or medical
2057	2057	cannabis product is not stored in a locked container that restricts access to
2058	2058	such container solely to individuals who are 21 years of age or older.
2059	2059	(d) This section shall be a part of and supplemental to the Kansas
2060	2060	criminal code.
2061	2061	(e) The provisions of this section shall expire on July 1, 2029.
2062	2062	New Sec. 29. (a) No law enforcement officer shall enforce any
2063	2063	violations of 18 U.S.C. § 922(g)(3) if the substance involved in such
2064	2064	violation is medical cannabis or medical cannabis products and such
2065	2065	person is a patient whose possession is authorized by the medical
2066	2066	cannabis pilot program act, section 1 et seq., and amendments thereto.
2067	2067	(b) As used in this section:
2068	2068	(1) "Law enforcement officer" means the same as defined in K.S.A.
2069	2069	74-5602, and amendments thereto; and
2070	2070	(2) "medical cannabis" and "medical cannabis product" mean the
2071	2071	same as defined in section 2, and amendments thereto.
2072	2072	(c) The provisions of this section shall expire on July 1, 2029.
2073	2073	New Sec. 30. (a) A covered entity, solely on the basis that an
2074	2074	individual consumes medical cannabis as authorized by the medical
2075	2075	cannabis pilot program act, section 1 et seq., and amendments thereto,
2076	2076	shall not:
2077	2077	(1) Consider such individual ineligible to receive an anatomical gift
2078	2078	or organ transplant;
2079	2079	(2) deny medical and other services related to organ transplantation,
2080	2080	including evaluation, surgery, counseling and post-transplantation
2081	2081	treatment and services;
2082	2082	(3) refuse to refer the individual to a transplant center or a related
2083	2083	specialist for the purpose of evaluation or receipt of an organ transplant;
2084	2084	(4) refuse to place such individual on an organ transplant waiting list;
2085	2085	or
2086	2086	(5) place such individual at a lower-priority position on an organ
2087	2087	transplant waiting list than the position at which such individual would
2088	2088	have been placed if not for such individual's consumption of medical
2089	2089	cannabis or medical cannabis products.
2090	2090	(b) A covered entity may consider an individual's consumption of
2091	2091	medical cannabis or medical cannabis products when making treatment or
2092	2092	coverage recommendations or decisions, solely to the extent that such
2093	2093	consumption has been found by a physician, following an individualized
2094	2094	evaluation of the individual, to be medically significant to the provision of
2095	2095	the anatomical gift.
2096	2096	(c) Nothing in this section shall be construed to require a covered
2097	2097	1
2098	2098	2
2099	2099	3
2100	2100	4
2101	2101	5
2102	2102	6
2103	2103	7
2104	2104	8
2105	2105	9
2106	2106	10
2107	2107	11
2108	2108	12
2109	2109	13
2110	2110	14
2111	2111	15
2112	2112	16
2113	2113	17
2114	2114	18
2115	2115	19
2116	2116	20
2117	2117	21
2118	2118	22
2119	2119	23
2120	2120	24
2121	2121	25
2122	2122	26
2123	2123	27
2124	2124	28
2125	2125	29
2126	2126	30
2127	2127	31
2128	2128	32
2129	2129	33
2130	2130	34
2131	2131	35
2132	2132	36
2133	2133	37
2134	2134	38
2135	2135	39
2136	2136	40
2137	2137	41
2138	2138	42
2139	2139	43 SB 555 26
2140	2140	entity to make a referral or recommendation for or perform a medically
2141	2141	inappropriate organ transplant.
2142	2142	(d) As used in this section:
2143	2143	(1) The terms "anatomical gift," "covered entity" and "organ
2144	2144	transplant" mean the same as defined in K.S.A. 65-3276, and amendments
2145	2145	thereto; and
2146	2146	(2) the term "medical cannabis" means the same as defined in section
2147	2147	2, and amendments thereto.
2148	2148	(e) The provisions of this section shall expire on July 1, 2029.
2149	2149	New Sec. 31. (a) No order shall be issued pursuant to K.S.A. 38-
2150	2150	2242, 38-2243 or 38-2244, and amendments thereto, if the sole basis for
2151	2151	the threat to the child's safety or welfare is that the child resides with an
2152	2152	individual who consumes medical cannabis or medical cannabis products
2153	2153	as authorized by the medical cannabis pilot program act, section 1 et seq.,
2154	2154	and amendments thereto.
2155	2155	(b) This section shall be a part of and supplemental to the revised
2156	2156	Kansas code for care of children.
2157	2157	(c) The provisions of this section shall expire on July 1, 2029.
2158	2158	New Sec. 32. (a) Notwithstanding the provisions of K.S.A. 65-2836,
2159	2159	and amendments thereto, the board shall not revoke, suspend or limit a
2160	2160	physician's license, publicly censure a physician or place a physician's
2161	2161	license under probationary conditions for any of the following:
2162	2162	(1) The physician has:
2163	2163	(A) Advised a patient about the possible benefits and risks of using
2164	2164	medical cannabis; or
2165	2165	(B) advised the patient that using medical cannabis may mitigate the
2166	2166	patient's symptoms; or
2167	2167	(2) the physician is a patient or caregiver and possesses or has
2168	2168	possessed or uses or has used medical cannabis or medical cannabis
2169	2169	products as authorized by the medical cannabis pilot program act, section
2170	2170	1 et seq., and amendments thereto.
2171	2171	(b) As used in this section, the terms "caregiver," "medical cannabis,"
2172	2172	"medical cannabis product," and "patient" mean the same as such terms are
2173	2173	defined in section 2, and amendments thereto.
2174	2174	(c) The provisions of this section shall expire on July 1, 2029.
2175	2175	New Sec. 33. (a) Notwithstanding the provisions of K.S.A. 65-28a05,
2176	2176	and amendments thereto, the board shall not revoke, suspend or limit a
2177	2177	physician assistant's license, publicly or privately censure a physician
2178	2178	assistant or deny an application for a license or for reinstatement of a
2179	2179	license for any of the following:
2180	2180	(1) The physician assistant has:
2181	2181	(A) Advised a patient about the possible benefits and risks of using
2182	2182	medical cannabis; or
2183	2183	1
2184	2184	2
2185	2185	3
2186	2186	4
2187	2187	5
2188	2188	6
2189	2189	7
2190	2190	8
2191	2191	9
2192	2192	10
2193	2193	11
2194	2194	12
2195	2195	13
2196	2196	14
2197	2197	15
2198	2198	16
2199	2199	17
2200	2200	18
2201	2201	19
2202	2202	20
2203	2203	21
2204	2204	22
2205	2205	23
2206	2206	24
2207	2207	25
2208	2208	26
2209	2209	27
2210	2210	28
2211	2211	29
2212	2212	30
2213	2213	31
2214	2214	32
2215	2215	33
2216	2216	34
2217	2217	35
2218	2218	36
2219	2219	37
2220	2220	38
2221	2221	39
2222	2222	40
2223	2223	41
2224	2224	42
2225	2225	43 SB 555 27
2226	2226	(B) advised the patient that using medical cannabis may mitigate the
2227	2227	patient's symptoms; or
2228	2228	(2) the physician assistant is a patient or caregiver and possesses or
2229	2229	has possessed or uses or has used medical cannabis or medical cannabis
2230	2230	products as authorized by the medical cannabis pilot program act, section
2231	2231	1 et seq., and amendments thereto.
2232	2232	(b) As used in this section, the terms "caregiver," "medical cannabis,"
2233	2233	"medical cannabis product" and "patient" mean the same as such terms are
2234	2234	defined in section 2, and amendments thereto.
2235	2235	(c) The provisions of this section shall expire on July 1, 2029.
2236	2236	New Sec. 34. (a) Notwithstanding any other provision of law, any
2237	2237	person, board, commission or similar body that determines the
2238	2238	qualifications of individuals for licensure, certification or registration shall
2239	2239	not disqualify an individual from licensure, certification or registration
2240	2240	solely because such individual consumes medical cannabis or medical
2241	2241	cannabis products as authorized by the medical cannabis pilot program act,
2242	2242	section 1 et seq., and amendments thereto.
2243	2243	(b) The provisions of this section shall not apply to the:
2244	2244	(1) Kansas commission on peace officers' standards and training;
2245	2245	(2) Kansas highway patrol; or
2246	2246	(3) office of the attorney general.
2247	2247	(c) The provisions of this section shall expire on July 1, 2029.
2248	2248	New Sec. 35. (a) A tax is hereby imposed upon the privilege of
2249	2249	selling medical cannabis and medical cannabis products in this state by
2250	2250	any medical cannabis operator at the rate of 8% on the gross receipts
2251	2251	received from the sale of medical cannabis and medical cannabis products
2252	2252	to patients and caregivers holding a valid medical cannabis certificate as
2253	2253	authorized by the medical cannabis pilot program act, section 1 et seq., and
2254	2254	amendments thereto. The tax imposed by this section shall be paid by the
2255	2255	patient or caregiver at the time of purchase.
2256	2256	(b) On or before the 20
2257	2257	th
2258	2258	day of each calendar month, every medical
2259	2259	cannabis operator shall file a return with the director of taxation showing
2260	2260	the quantity of medical cannabis and medical cannabis products sold to
2261	2261	patients and caregivers within this state during the preceding calendar
2262	2262	month. Each return shall be accompanied by a remittance for the full tax
2263	2263	liability shown.
2264	2264	(c) All moneys received by the director of taxation or the director's
2265	2265	designee from taxes imposed by this section shall be remitted to the state
2266	2266	treasurer in accordance with the provisions of K.S.A. 75-4215, and
2267	2267	amendments thereto. Upon receipt of each such remittance, the state
2268	2268	treasurer shall deposit the entire amount in the state treasury. Subject to the
2269	2269	maintenance requirements of the medical cannabis refund fund established
2270	2270	by section 38, and amendments thereto, an amount equal to 20% of such
2271	2271	1
2272	2272	2
2273	2273	3
2274	2274	4
2275	2275	5
2276	2276	6
2277	2277	7
2278	2278	8
2279	2279	9
2280	2280	10
2281	2281	11
2282	2282	12
2283	2283	13
2284	2284	14
2285	2285	15
2286	2286	16
2287	2287	17
2288	2288	18
2289	2289	19
2290	2290	20
2291	2291	21
2292	2292	22
2293	2293	23
2294	2294	24
2295	2295	25
2296	2296	26
2297	2297	27
2298	2298	28
2299	2299	29
2300	2300	30
2301	2301	31
2302	2302	32
2303	2303	33
2304	2304	34
2305	2305	35
2306	2306	36
2307	2307	37
2308	2308	38
2309	2309	39
2310	2310	40
2311	2311	41
2312	2312	42
2313	2313	43 SB 555 28
2314	2314	deposit shall be credited to the medical cannabis research and education
2315	2315	fund established by section 39, and amendments thereto, and the
2316	2316	remaining amount of any such deposit shall be credited to the state general
2317	2317	fund.
2318	2318	New Sec. 36. The director of taxation shall have the power to require
2319	2319	any medical cannabis operator to furnish additional information deemed
2320	2320	necessary for the purpose of computing the amount of the taxes due
2321	2321	pursuant to section 35, and amendments thereto, and, for such purpose, to
2322	2322	examine all books, records and files of such persons or entities. The
2323	2323	director also shall have the power to issue subpoenas and examine
2324	2324	witnesses under oath, and if any witness shall fail or refuse to appear at the
2325	2325	request of the director, or refuse access to books, records and files, the
2326	2326	district court of the proper county, or the judge thereof, on application of
2327	2327	the director, shall compel obedience by proceedings for contempt, as in the
2328	2328	case of disobedience of the requirements of a subpoena issued from such
2329	2329	court or a refusal to testify therein.
2330	2330	New Sec. 37. The provisions of K.S.A. 75-5133, 79-3610, 79-3611,
2331	2331	79-3612, 79-3613, 79-3615 and 79-3617, and amendments thereto,
2332	2332	relating to the assessment, collection, appeal and administration of the
2333	2333	retailers' sales tax, insofar as practicable, shall have full force and effect
2334	2334	with respect to taxes, penalties and fines imposed by sections 35 and 36,
2335	2335	and amendments thereto.
2336	2336	New Sec. 38. There is hereby established in the state treasury the
2337	2337	medical cannabis refund fund. The medical cannabis refund fund shall be
2338	2338	held by the state treasurer for prompt refunding of all overpayments of the
2339	2339	tax levied and collected pursuant to section 35, and amendments thereto.
2340	2340	The medical cannabis refund fund shall be maintained in an amount
2341	2341	determined by the secretary of revenue as necessary to meet current
2342	2342	refunding requirements, but such amount shall not exceed $10,000.
2343	2343	New Sec. 39. There is hereby established in the state treasury the
2344	2344	medical cannabis research and education fund to be administered by the
2345	2345	secretary for health and environment. All expenditures and transfers from
2346	2346	the medical cannabis research and education fund shall be made in
2347	2347	accordance with appropriation acts upon warrants of the director of
2348	2348	accounts and reports issued pursuant to vouchers approved by the
2349	2349	secretary or the secretary's designee. All moneys credited to such fund
2350	2350	shall be expended or transferred only for the purposes of medical cannabis
2351	2351	research and education.
2352	2352	New Sec. 40. For purposes of sections 35 through 40, and
2353	2353	amendments thereto, the terms "medical cannabis," "medical cannabis
2354	2354	operator" and "medical cannabis product" mean the same as defined in
2355	2355	section 2, and amendments thereto.
2356	2356	New Sec. 41. The provisions of sections 35 through 41, and
2357	2357	1
2358	2358	2
2359	2359	3
2360	2360	4
2361	2361	5
2362	2362	6
2363	2363	7
2364	2364	8
2365	2365	9
2366	2366	10
2367	2367	11
2368	2368	12
2369	2369	13
2370	2370	14
2371	2371	15
2372	2372	16
2373	2373	17
2374	2374	18
2375	2375	19
2376	2376	20
2377	2377	21
2378	2378	22
2379	2379	23
2380	2380	24
2381	2381	25
2382	2382	26
2383	2383	27
2384	2384	28
2385	2385	29
2386	2386	30
2387	2387	31
2388	2388	32
2389	2389	33
2390	2390	34
2391	2391	35
2392	2392	36
2393	2393	37
2394	2394	38
2395	2395	39
2396	2396	40
2397	2397	41
2398	2398	42
2399	2399	43 SB 555 29
2400	2400	amendments thereto, shall expire on July 1, 2029.
2401	2401	Sec. 42. K.S.A. 21-5703 is hereby amended to read as follows: 21-
2402	2402	5703. (a) It shall be unlawful for any person to manufacture any controlled
2403	2403	substance or controlled substance analog.
2404	2404	(b) Violation or attempted violation of subsection (a) is a:
2405	2405	(1) Drug severity level 2 felony, except as provided in subsections (b)
2406	2406	(2) and (b)(3);
2407	2407	(2) drug severity level 1 felony if:
2408	2408	(A) The controlled substance is not methamphetamine, as defined by
2409	2409	K.S.A. 65-4107(d)(3) or (f)(1), and amendments thereto, or an analog
2410	2410	thereof;
2411	2411	(B) the controlled substance is not a fentanyl-related controlled
2412	2412	substance; and
2413	2413	(C) the offender has a prior conviction for unlawful manufacturing of
2414	2414	a controlled substance under this section, K.S.A. 65-4159, prior to its
2415	2415	repeal, K.S.A. 2010 Supp. 21-36a03, prior to its transfer, or a substantially
2416	2416	similar offense from another jurisdiction and the substance was not
2417	2417	methamphetamine, as defined by K.S.A. 65-4107(d)(3) or (f)(1), and
2418	2418	amendments thereto, or an analog thereof, in any such prior conviction;
2419	2419	and
2420	2420	(3) drug severity level 1 felony if the controlled substance is
2421	2421	methamphetamine, as defined by K.S.A. 65-4107(d)(3) or (f)(1), and
2422	2422	amendments thereto, or an analog thereof, or is a fentanyl-related
2423	2423	controlled substance.
2424	2424	(c) The provisions of K.S.A. 21-5301(d), and amendments thereto,
2425	2425	shall not apply to a violation of attempting to unlawfully manufacture any
2426	2426	controlled substance or controlled substance analog pursuant to this
2427	2427	section.
2428	2428	(d) For persons arrested and charged under this section, bail shall be
2429	2429	at least $50,000 cash or surety, and such person shall not be released upon
2430	2430	the person's own recognizance pursuant to K.S.A. 22-2802, and
2431	2431	amendments thereto, unless the court determines, on the record, that the
2432	2432	defendant is not likely to re-offend, the court imposes pretrial supervision,
2433	2433	or the defendant agrees to participate in a licensed or certified drug
2434	2434	treatment program.
2435	2435	(e) The sentence of a person who violates this section shall not be
2436	2436	subject to statutory provisions for suspended sentence, community service
2437	2437	work or probation.
2438	2438	(f) The sentence of a person who violates this section, K.S.A. 65-
2439	2439	4159, prior to its repeal or K.S.A. 2010 Supp. 21-36a03, prior to its
2440	2440	transfer, shall not be reduced because these sections prohibit conduct
2441	2441	identical to that prohibited by K.S.A. 65-4161 or 65-4163, prior to their
2442	2442	repeal, K.S.A. 2010 Supp. 21-36a05, prior to its transfer, or K.S.A. 21-
2443	2443	1
2444	2444	2
2445	2445	3
2446	2446	4
2447	2447	5
2448	2448	6
2449	2449	7
2450	2450	8
2451	2451	9
2452	2452	10
2453	2453	11
2454	2454	12
2455	2455	13
2456	2456	14
2457	2457	15
2458	2458	16
2459	2459	17
2460	2460	18
2461	2461	19
2462	2462	20
2463	2463	21
2464	2464	22
2465	2465	23
2466	2466	24
2467	2467	25
2468	2468	26
2469	2469	27
2470	2470	28
2471	2471	29
2472	2472	30
2473	2473	31
2474	2474	32
2475	2475	33
2476	2476	34
2477	2477	35
2478	2478	36
2479	2479	37
2480	2480	38
2481	2481	39
2482	2482	40
2483	2483	41
2484	2484	42
2485	2485	43 SB 555 30
2486	2486	5705, and amendments thereto.
2487	2487	(g) The provisions of this section shall not apply to a medical
2488	2488	cannabis operator, as such term is defined in section 2, and amendments
2489	2489	thereto, that is producing medical cannabis or medical cannabis products,
2490	2490	as such terms are defined in section 2, and amendments thereto, when
2491	2491	used for acts authorized by the medical cannabis pilot program act,
2492	2492	section 1 et seq., and amendments thereto.
2493	2493	Sec. 43. K.S.A. 21-5705 is hereby amended to read as follows: 21-
2494	2494	5705. (a) It shall be unlawful for any person to distribute or possess with
2495	2495	the intent to distribute any of the following controlled substances or
2496	2496	controlled substance analogs thereof:
2497	2497	(1) Opiates, opium or narcotic drugs, or any stimulant designated in
2498	2498	subsection (d)(1), (d)(3) or (f)(1) of K.S.A. 65-4107(d)(1), (d)(3) or (f)(1),
2499	2499	and amendments thereto;
2500	2500	(2) any depressant designated in subsection (e) of K.S.A. 65-4105(e),
2501	2501	subsection (e) of K.S.A. 65-4107(e), subsection (b) or (c) of K.S.A. 65-
2502	2502	4109(b) or (c) or subsection (b) of K.S.A. 65-4111(b), and amendments
2503	2503	thereto;
2504	2504	(3) any stimulant designated in subsection (f) of K.S.A. 65-4105(f),
2505	2505	subsection (d)(2), (d)(4), (d)(5) or (f)(2) of K.S.A. 65-4107(d)(2), (d)(4),
2506	2506	(d)(5) or (f)(2) or subsection (e) of K.S.A. 65-4109(e), and amendments
2507	2507	thereto;
2508	2508	(4) any hallucinogenic drug designated in subsection (d) of K.S.A.
2509	2509	65-4105(d), subsection (g) of K.S.A. 65-4107(g) or subsection (g) of
2510	2510	K.S.A. 65-4109(g), and amendments thereto;
2511	2511	(5) any substance designated in subsection (g) of K.S.A. 65-4105(g)
2512	2512	and subsection (c), (d), (e), (f) or (g) of K.S.A. 65-4111(c), (d), (e), (f) or
2513	2513	(g), and amendments thereto;
2514	2514	(6) any anabolic steroids as defined in subsection (f) of K.S.A. 65-
2515	2515	4109(f), and amendments thereto; or
2516	2516	(7) any substance designated in subsection (h) of K.S.A. 65-4105(h),
2517	2517	and amendments thereto.
2518	2518	(b) It shall be unlawful for any person to distribute or possess with
2519	2519	the intent to distribute a controlled substance or a controlled substance
2520	2520	analog designated in K.S.A. 65-4113, and amendments thereto.
2521	2521	(c) It shall be unlawful for any person to cultivate any controlled
2522	2522	substance or controlled substance analog listed in subsection (a).
2523	2523	(d) (1) Except as provided further, violation of subsection (a) is a:
2524	2524	(A) Drug severity level 4 felony if the quantity of the material was
2525	2525	less than 3.5 grams;
2526	2526	(B) drug severity level 3 felony if the quantity of the material was at
2527	2527	least 3.5 grams but less than 100 grams;
2528	2528	(C) drug severity level 2 felony if the quantity of the material was at
2529	2529	1
2530	2530	2
2531	2531	3
2532	2532	4
2533	2533	5
2534	2534	6
2535	2535	7
2536	2536	8
2537	2537	9
2538	2538	10
2539	2539	11
2540	2540	12
2541	2541	13
2542	2542	14
2543	2543	15
2544	2544	16
2545	2545	17
2546	2546	18
2547	2547	19
2548	2548	20
2549	2549	21
2550	2550	22
2551	2551	23
2552	2552	24
2553	2553	25
2554	2554	26
2555	2555	27
2556	2556	28
2557	2557	29
2558	2558	30
2559	2559	31
2560	2560	32
2561	2561	33
2562	2562	34
2563	2563	35
2564	2564	36
2565	2565	37
2566	2566	38
2567	2567	39
2568	2568	40
2569	2569	41
2570	2570	42
2571	2571	43 SB 555 31
2572	2572	least 100 grams but less than 1 kilogram; and
2573	2573	(D) drug severity level 1 felony if the quantity of the material was 1
2574	2574	kilogram or more.
2575	2575	(2) Violation of subsection (a) with respect to material containing any
2576	2576	quantity of marijuana, or an analog thereof, is a:
2577	2577	(A) Drug severity level 4 felony if the quantity of the material was
2578	2578	less than 25 grams;
2579	2579	(B) drug severity level 3 felony if the quantity of the material was at
2580	2580	least 25 grams but less than 450 grams;
2581	2581	(C) drug severity level 2 felony if the quantity of the material was at
2582	2582	least 450 grams but less than 30 kilograms; and
2583	2583	(D) drug severity level 1 felony if the quantity of the material was 30
2584	2584	kilograms or more.
2585	2585	(3) Violation of subsection (a) with respect to material containing any
2586	2586	quantity of heroin, as defined by subsection (c)(1) of K.S.A. 65-4105(c)
2587	2587	(1), and amendments thereto, or methamphetamine, as defined by
2588	2588	subsection (d)(3) or (f)(1) of K.S.A. 65-4107(d)(3) or (f)(1), and
2589	2589	amendments thereto, or an analog thereof, is a:
2590	2590	(A) Drug severity level 4 felony if the quantity of the material was
2591	2591	less than 1 gram;
2592	2592	(B) drug severity level 3 felony if the quantity of the material was at
2593	2593	least 1 gram but less than 3.5 grams;
2594	2594	(C) drug severity level 2 felony if the quantity of the material was at
2595	2595	least 3.5 grams but less than 100 grams; and
2596	2596	(D) drug severity level 1 felony if the quantity of the material was
2597	2597	100 grams or more.
2598	2598	(4) Violation of subsection (a) with respect to material containing any
2599	2599	quantity of a controlled substance designated in K.S.A. 65-4105, 65-4107,
2600	2600	65-4109 or 65-4111, and amendments thereto, or an analog thereof,
2601	2601	distributed by dosage unit, is a:
2602	2602	(A) Drug severity level 4 felony if the number of dosage units was
2603	2603	fewer than 10;
2604	2604	(B) drug severity level 3 felony if the number of dosage units was at
2605	2605	least 10 but less than 100;
2606	2606	(C) drug severity level 2 felony if the number of dosage units was at
2607	2607	least 100 but less than 1,000; and
2608	2608	(D) drug severity level 1 felony if the number of dosage units was
2609	2609	1,000 or more.
2610	2610	(5) For any violation of subsection (a), the severity level of the
2611	2611	offense shall be increased one level if the controlled substance or
2612	2612	controlled substance analog was distributed or possessed with the intent to
2613	2613	distribute on or within 1,000 feet of any school property.
2614	2614	(6) Violation of subsection (b) is a:
2615	2615	1
2616	2616	2
2617	2617	3
2618	2618	4
2619	2619	5
2620	2620	6
2621	2621	7
2622	2622	8
2623	2623	9
2624	2624	10
2625	2625	11
2626	2626	12
2627	2627	13
2628	2628	14
2629	2629	15
2630	2630	16
2631	2631	17
2632	2632	18
2633	2633	19
2634	2634	20
2635	2635	21
2636	2636	22
2637	2637	23
2638	2638	24
2639	2639	25
2640	2640	26
2641	2641	27
2642	2642	28
2643	2643	29
2644	2644	30
2645	2645	31
2646	2646	32
2647	2647	33
2648	2648	34
2649	2649	35
2650	2650	36
2651	2651	37
2652	2652	38
2653	2653	39
2654	2654	40
2655	2655	41
2656	2656	42
2657	2657	43 SB 555 32
2658	2658	(A) Class A person misdemeanor, except as provided in subsection
2659	2659	(d)(6)(B) subparagraph (B); and
2660	2660	(B) nondrug severity level 7, person felony if the substance was
2661	2661	distributed to or possessed with the intent to distribute to a minor.
2662	2662	(7) Violation of subsection (c) is a:
2663	2663	(A) Drug severity level 3 felony if the number of plants cultivated
2664	2664	was more than 4 but fewer than 50;
2665	2665	(B) drug severity level 2 felony if the number of plants cultivated was
2666	2666	at least 50 but fewer than 100; and
2667	2667	(C) drug severity level 1 felony if the number of plants cultivated was
2668	2668	100 or more.
2669	2669	(e) In any prosecution under this section, there shall be a rebuttable
2670	2670	presumption of an intent to distribute if any person possesses the following
2671	2671	quantities of controlled substances or analogs thereof:
2672	2672	(1) 450 grams or more of marijuana;
2673	2673	(2) 3.5 grams or more of heroin or methamphetamine;
2674	2674	(3) 100 dosage units or more containing a controlled substance; or
2675	2675	(4) 100 grams or more of any other controlled substance.
2676	2676	(f) It shall not be a defense to charges arising under this section that
2677	2677	the defendant:
2678	2678	(1) Was acting in an agency relationship on behalf of any other party
2679	2679	in a transaction involving a controlled substance or controlled substance
2680	2680	analog;
2681	2681	(2) did not know the quantity of the controlled substance or
2682	2682	controlled substance analog; or
2683	2683	(3) did not know the specific controlled substance or controlled
2684	2684	substance analog contained in the material that was distributed or
2685	2685	possessed with the intent to distribute.
2686	2686	(g) The provisions of (a)(4) and (a)(5) shall not apply to a medical
2687	2687	cannabis operator, as such term is defined in section 2, and amendments
2688	2688	thereto, or a state contracted laboratory or any employee or agent thereof
2689	2689	that is growing, testing, processing, distributing or selling medical
2690	2690	cannabis or medical cannabis products, as such terms are defined in
2691	2691	section 2, and amendments thereto, in accordance with the medical
2692	2692	cannabis pilot program act, section 1 et seq., and amendments thereto.
2693	2693	(h) As used in this section:
2694	2694	(1) "Material" means the total amount of any substance, including a
2695	2695	compound or a mixture, which that contains any quantity of a controlled
2696	2696	substance or controlled substance analog.
2697	2697	(2) "Dosage unit" means a controlled substance or controlled
2698	2698	substance analog distributed or possessed with the intent to distribute as a
2699	2699	discrete unit, including but not limited to, one pill, one capsule or one
2700	2700	microdot, and not distributed by weight.
2701	2701	1
2702	2702	2
2703	2703	3
2704	2704	4
2705	2705	5
2706	2706	6
2707	2707	7
2708	2708	8
2709	2709	9
2710	2710	10
2711	2711	11
2712	2712	12
2713	2713	13
2714	2714	14
2715	2715	15
2716	2716	16
2717	2717	17
2718	2718	18
2719	2719	19
2720	2720	20
2721	2721	21
2722	2722	22
2723	2723	23
2724	2724	24
2725	2725	25
2726	2726	26
2727	2727	27
2728	2728	28
2729	2729	29
2730	2730	30
2731	2731	31
2732	2732	32
2733	2733	33
2734	2734	34
2735	2735	35
2736	2736	36
2737	2737	37
2738	2738	38
2739	2739	39
2740	2740	40
2741	2741	41
2742	2742	42
2743	2743	43 SB 555 33
2744	2744	(A) For steroids, or controlled substances in liquid solution legally
2745	2745	manufactured for prescription use, or an analog thereof, "dosage unit"
2746	2746	means the smallest medically approved dosage unit, as determined by the
2747	2747	label, materials provided by the manufacturer, a prescribing authority,
2748	2748	licensed health care professional or other qualified health authority.
2749	2749	(B) For illegally manufactured controlled substances in liquid
2750	2750	solution, or controlled substances in liquid products not intended for
2751	2751	ingestion by human beings, or an analog thereof, "dosage unit" means 10
2752	2752	milligrams, including the liquid carrier medium, except as provided in
2753	2753	subsection (g)(2)(C) subparagraph (C).
2754	2754	(C) For lysergic acid diethylamide (LSD) in liquid form, or an analog
2755	2755	thereof, a dosage unit is defined as 0.4 milligrams, including the liquid
2756	2756	medium.
2757	2757	Sec. 44. K.S.A. 21-5706 is hereby amended to read as follows: 21-
2758	2758	5706. (a) It shall be unlawful for any person to possess any opiates, opium
2759	2759	or narcotic drugs, or any stimulant designated in K.S.A. 65-4107(d)(1), (d)
2760	2760	(3) or (f)(1), and amendments thereto, or a controlled substance analog
2761	2761	thereof.
2762	2762	(b) It shall be unlawful for any person to possess any of the following
2763	2763	controlled substances or controlled substance analogs thereof:
2764	2764	(1) Any depressant designated in K.S.A. 65-4105(e), 65-4107(e), 65-
2765	2765	4109(b) or (c) or 65-4111(b), and amendments thereto;
2766	2766	(2) any stimulant designated in K.S.A. 65-4105(f), 65-4107(d)(2), (d)
2767	2767	(4), (d)(5) or (f)(2) or 65-4109(e), and amendments thereto;
2768	2768	(3) any hallucinogenic drug designated in K.S.A. 65-4105(d), 65-
2769	2769	4107(g) or 65-4109(g), and amendments thereto;
2770	2770	(4) any substance designated in K.S.A. 65-4105(g) and 65-4111(c),
2771	2771	(d), (e), (f) or (g), and amendments thereto;
2772	2772	(5) any anabolic steroids as defined in K.S.A. 65-4109(f), and
2773	2773	amendments thereto;
2774	2774	(6) any substance designated in K.S.A. 65-4113, and amendments
2775	2775	thereto; or
2776	2776	(7) any substance designated in K.S.A. 65-4105(h), and amendments
2777	2777	thereto.
2778	2778	(c) (1) Violation of subsection (a) is a drug severity level 5 felony.
2779	2779	(2) Except as provided in subsection (c)(3):
2780	2780	(A) Violation of subsection (b) is a class A nonperson misdemeanor,
2781	2781	except as provided in subparagraph (B); and
2782	2782	(B) violation of subsection (b)(1) through (b)(5) or (b)(7) is a drug
2783	2783	severity level 5 felony if that person has a prior conviction under such
2784	2784	subsection, under K.S.A. 65-4162, prior to its repeal, under a substantially
2785	2785	similar offense from another jurisdiction, or under any city ordinance or
2786	2786	county resolution for a substantially similar offense if the substance
2787	2787	1
2788	2788	2
2789	2789	3
2790	2790	4
2791	2791	5
2792	2792	6
2793	2793	7
2794	2794	8
2795	2795	9
2796	2796	10
2797	2797	11
2798	2798	12
2799	2799	13
2800	2800	14
2801	2801	15
2802	2802	16
2803	2803	17
2804	2804	18
2805	2805	19
2806	2806	20
2807	2807	21
2808	2808	22
2809	2809	23
2810	2810	24
2811	2811	25
2812	2812	26
2813	2813	27
2814	2814	28
2815	2815	29
2816	2816	30
2817	2817	31
2818	2818	32
2819	2819	33
2820	2820	34
2821	2821	35
2822	2822	36
2823	2823	37
2824	2824	38
2825	2825	39
2826	2826	40
2827	2827	41
2828	2828	42
2829	2829	43 SB 555 34
2830	2830	involved was 3, 4-methylenedioxymethamphetamine (MDMA), marijuana
2831	2831	as designated in K.S.A. 65-4105(d), and amendments thereto, or any
2832	2832	substance designated in K.S.A. 65-4105(h), and amendments thereto, or an
2833	2833	analog thereof.
2834	2834	(3) If the substance involved is marijuana, as designated in K.S.A.
2835	2835	65-4105(d), and amendments thereto, or tetrahydrocannabinols, as
2836	2836	designated in K.S.A. 65-4105(h), and amendments thereto, violation of
2837	2837	subsection (b) is a:
2838	2838	(A) Class B nonperson misdemeanor, except as provided in
2839	2839	subparagraphs (B) and (C);
2840	2840	(B) class A nonperson misdemeanor if that person has a prior
2841	2841	conviction under such subsection, under K.S.A. 65-4162, prior to its
2842	2842	repeal, under a substantially similar offense from another jurisdiction, or
2843	2843	under any city ordinance or county resolution for a substantially similar
2844	2844	offense; and
2845	2845	(C) drug severity level 5 felony if that person has two or more prior
2846	2846	convictions under such subsection, under K.S.A. 65-4162, prior to its
2847	2847	repeal, under a substantially similar offense from another jurisdiction, or
2848	2848	under any city ordinance or county resolution for a substantially similar
2849	2849	offense.
2850	2850	(d) It shall be an affirmative defense to prosecution under this section
2851	2851	arising out of a person's possession of any cannabidiol treatment
2852	2852	preparation if the person:
2853	2853	(1) Has a debilitating medical condition, as defined in K.S.A. 2023
2854	2854	Supp. 65-6235, and amendments thereto, or is the parent or guardian of a
2855	2855	minor child who has such debilitating medical condition;
2856	2856	(2) is possessing a cannabidiol treatment preparation, as defined in
2857	2857	K.S.A. 2023 Supp. 65-6235, and amendments thereto, that is being used to
2858	2858	treat such debilitating medical condition; and
2859	2859	(3) has possession of a letter, at all times while the person has
2860	2860	possession of the cannabidiol treatment preparation, that:
2861	2861	(A) Shall be shown to a law enforcement officer on such officer's
2862	2862	request;
2863	2863	(B) is dated within the preceding 15 months and signed by the
2864	2864	physician licensed to practice medicine and surgery in Kansas who
2865	2865	diagnosed the debilitating medical condition;
2866	2866	(C) is on such physician's letterhead; and
2867	2867	(D) identifies the person or the person's minor child as such
2868	2868	physician's patient and identifies the patient's debilitating medical
2869	2869	condition.
2870	2870	(e) If the substance involved is medical cannabis or medical cannabis
2871	2871	products, as such terms are defined in section 2, and amendments thereto,
2872	2872	the provisions of subsections (b) and (c) shall not apply to any person who
2873	2873	1
2874	2874	2
2875	2875	3
2876	2876	4
2877	2877	5
2878	2878	6
2879	2879	7
2880	2880	8
2881	2881	9
2882	2882	10
2883	2883	11
2884	2884	12
2885	2885	13
2886	2886	14
2887	2887	15
2888	2888	16
2889	2889	17
2890	2890	18
2891	2891	19
2892	2892	20
2893	2893	21
2894	2894	22
2895	2895	23
2896	2896	24
2897	2897	25
2898	2898	26
2899	2899	27
2900	2900	28
2901	2901	29
2902	2902	30
2903	2903	31
2904	2904	32
2905	2905	33
2906	2906	34
2907	2907	35
2908	2908	36
2909	2909	37
2910	2910	38
2911	2911	39
2912	2912	40
2913	2913	41
2914	2914	42
2915	2915	43 SB 555 35
2916	2916	holds a valid medical cannabis certificate issued pursuant to the medical
2917	2917	cannabis pilot program act, section 1 et seq., and amendments thereto,
2918	2918	and whose possession is authorized by such act.
2919	2919	(f) It shall not be a defense to charges arising under this section that
2920	2920	the defendant was acting in an agency relationship on behalf of any other
2921	2921	party in a transaction involving a controlled substance or controlled
2922	2922	substance analog.
2923	2923	Sec. 45. K.S.A. 21-5707 is hereby amended to read as follows: 21-
2924	2924	5707. (a) It shall be unlawful for any person to knowingly or intentionally
2925	2925	use any communication facility:
2926	2926	(1) In committing, causing, or facilitating the commission of any
2927	2927	felony under K.S.A. 21-5703, 21-5705 or 21-5706, and amendments
2928	2928	thereto; or
2929	2929	(2) in any attempt to commit, any conspiracy to commit, or any
2930	2930	criminal solicitation of any felony under K.S.A. 21-5703, 21-5705 or 21-
2931	2931	5706, and amendments thereto. Each separate use of a communication
2932	2932	facility may be charged as a separate offense under this subsection.
2933	2933	(b) Violation of subsection (a) is a nondrug severity level 8,
2934	2934	nonperson felony.
2935	2935	(c) The provisions of this section shall not apply to any person using
2936	2936	communication facilities for activities authorized by the medical cannabis
2937	2937	pilot program act, section 1 et seq., and amendments thereto.
2938	2938	(d) As used in this section, "communication facility" means any and
2939	2939	all public and private instrumentalities used or useful in the transmission
2940	2940	of writing, signs, signals, pictures or sounds of all kinds and includes
2941	2941	telephone, wire, radio, computer, computer networks, beepers, pagers and
2942	2942	all other means of communication.
2943	2943	Sec. 46. K.S.A. 21-5709 is hereby amended to read as follows: 21-
2944	2944	5709. (a) It shall be unlawful for any person to possess ephedrine,
2945	2945	pseudoephedrine, red phosphorus, lithium metal, sodium metal, iodine,
2946	2946	anhydrous ammonia, pressurized ammonia or phenylpropanolamine, or
2947	2947	their salts, isomers or salts of isomers with an intent to use the product to
2948	2948	manufacture a controlled substance.
2949	2949	(b) It shall be unlawful for any person to use or possess with intent to
2950	2950	use any drug paraphernalia to:
2951	2951	(1) Manufacture, cultivate, plant, propagate, harvest, test, analyze or
2952	2952	distribute a controlled substance; or
2953	2953	(2) store, contain, conceal, inject, ingest, inhale or otherwise
2954	2954	introduce a controlled substance into the human body.
2955	2955	(c) It shall be unlawful for any person to use or possess with intent to
2956	2956	use anhydrous ammonia or pressurized ammonia in a container not
2957	2957	approved for that chemical by the Kansas department of agriculture.
2958	2958	(d) It shall be unlawful for any person to purchase, receive or
2959	2959	1
2960	2960	2
2961	2961	3
2962	2962	4
2963	2963	5
2964	2964	6
2965	2965	7
2966	2966	8
2967	2967	9
2968	2968	10
2969	2969	11
2970	2970	12
2971	2971	13
2972	2972	14
2973	2973	15
2974	2974	16
2975	2975	17
2976	2976	18
2977	2977	19
2978	2978	20
2979	2979	21
2980	2980	22
2981	2981	23
2982	2982	24
2983	2983	25
2984	2984	26
2985	2985	27
2986	2986	28
2987	2987	29
2988	2988	30
2989	2989	31
2990	2990	32
2991	2991	33
2992	2992	34
2993	2993	35
2994	2994	36
2995	2995	37
2996	2996	38
2997	2997	39
2998	2998	40
2999	2999	41
3000	3000	42
3001	3001	43 SB 555 36
3002	3002	otherwise acquire at retail any compound, mixture or preparation
3003	3003	containing more than 3.6 grams of pseudoephedrine base or ephedrine
3004	3004	base in any single transaction or any compound, mixture or preparation
3005	3005	containing more than nine grams of pseudoephedrine base or ephedrine
3006	3006	base within any 30-day period.
3007	3007	(e) (1) Violation of subsection (a) is a drug severity level 3 felony;
3008	3008	(2) violation of subsection (b)(1) is a:
3009	3009	(A) Drug severity level 5 felony, except as provided in subsection (e)
3010	3010	(2)(B); and
3011	3011	(B) class B nonperson misdemeanor if the drug paraphernalia was
3012	3012	used to cultivate fewer than five marijuana plants;
3013	3013	(3) violation of subsection (b)(2) is a class B nonperson
3014	3014	misdemeanor;
3015	3015	(4) violation of subsection (c) is a drug severity level 5 felony; and
3016	3016	(5) violation of subsection (d) is a class A nonperson misdemeanor.
3017	3017	(f) For persons arrested and charged under subsection (a) or (c), bail
3018	3018	shall be at least $50,000 cash or surety, and such person shall not be
3019	3019	released upon the person's own recognizance pursuant to K.S.A. 22-2802,
3020	3020	and amendments thereto, unless the court determines, on the record, that
3021	3021	the defendant is not likely to reoffend, the court imposes pretrial
3022	3022	supervision or the defendant agrees to participate in a licensed or certified
3023	3023	drug treatment program.
3024	3024	(g) The provisions of subsection (b) shall not apply to any person
3025	3025	who holds a valid medical cannabis certificate issued pursuant to the
3026	3026	medical cannabis pilot program act, section 1 et seq., and amendments
3027	3027	thereto, whose possession of such equipment or material is used solely to
3028	3028	produce or for the administration of medical cannabis or medical
3029	3029	cannabis products, as such terms are defined in section 2, and
3030	3030	amendments thereto, in a manner authorized by the medical cannabis pilot
3031	3031	program act.
3032	3032	Sec. 47. K.S.A. 21-5710 is hereby amended to read as follows: 21-
3033	3033	5710. (a) It shall be unlawful for any person to advertise, market, label,
3034	3034	distribute or possess with the intent to distribute:
3035	3035	(1) Any product containing ephedrine, pseudoephedrine, red
3036	3036	phosphorus, lithium metal, sodium metal, iodine, anhydrous ammonia,
3037	3037	pressurized ammonia or phenylpropanolamine or their salts, isomers or
3038	3038	salts of isomers if the person knows or reasonably should know that the
3039	3039	purchaser will use the product to manufacture a controlled substance or
3040	3040	controlled substance analog; or
3041	3041	(2) any product containing ephedrine, pseudoephedrine or
3042	3042	phenylpropanolamine, or their salts, isomers or salts of isomers for
3043	3043	indication of stimulation, mental alertness, weight loss, appetite control,
3044	3044	energy or other indications not approved pursuant to the pertinent federal
3045	3045	1
3046	3046	2
3047	3047	3
3048	3048	4
3049	3049	5
3050	3050	6
3051	3051	7
3052	3052	8
3053	3053	9
3054	3054	10
3055	3055	11
3056	3056	12
3057	3057	13
3058	3058	14
3059	3059	15
3060	3060	16
3061	3061	17
3062	3062	18
3063	3063	19
3064	3064	20
3065	3065	21
3066	3066	22
3067	3067	23
3068	3068	24
3069	3069	25
3070	3070	26
3071	3071	27
3072	3072	28
3073	3073	29
3074	3074	30
3075	3075	31
3076	3076	32
3077	3077	33
3078	3078	34
3079	3079	35
3080	3080	36
3081	3081	37
3082	3082	38
3083	3083	39
3084	3084	40
3085	3085	41
3086	3086	42
3087	3087	43 SB 555 37
3088	3088	over-the-counter drug final monograph or tentative final monograph or
3089	3089	approved new drug application.
3090	3090	(b) It shall be unlawful for any person to distribute, possess with the
3091	3091	intent to distribute or manufacture with intent to distribute any drug
3092	3092	paraphernalia, knowing or under circumstances where one reasonably
3093	3093	should know that it will be used to manufacture or distribute a controlled
3094	3094	substance or controlled substance analog in violation of K.S.A. 21-5701
3095	3095	through 21-5717, and amendments thereto.
3096	3096	(c) It shall be unlawful for any person to distribute, possess with
3097	3097	intent to distribute or manufacture with intent to distribute any drug
3098	3098	paraphernalia, knowing or under circumstances where one reasonably
3099	3099	should know, that it will be used as such in violation of K.S.A. 21-5701
3100	3100	through 21-5717, and amendments thereto, except subsection (b) of K.S.A.
3101	3101	21-5706(b), and amendments thereto.
3102	3102	(d) It shall be unlawful for any person to distribute, possess with
3103	3103	intent to distribute or manufacture with intent to distribute any drug
3104	3104	paraphernalia, knowing, or under circumstances where one reasonably
3105	3105	should know, that it will be used as such in violation of subsection (b) of
3106	3106	K.S.A. 21-5706(b), and amendments thereto.
3107	3107	(e) (1) Violation of subsection (a) is a drug severity level 3 felony;
3108	3108	(2) violation of subsection (b) is a:
3109	3109	(A) Drug severity level 5 felony, except as provided in subsection (e)
3110	3110	(2)(B) subparagraph (B); and
3111	3111	(B) drug severity level 4 felony if the trier of fact makes a finding that
3112	3112	the offender distributed or caused drug paraphernalia to be distributed to a
3113	3113	minor or on or within 1,000 feet of any school property;
3114	3114	(3) violation of subsection (c) is a:
3115	3115	(A) Nondrug severity level 9, nonperson felony, except as provided in
3116	3116	subsection (e)(3)(B) subparagraph (B); and
3117	3117	(B) drug severity level 5 felony if the trier of fact makes a finding that
3118	3118	the offender distributed or caused drug paraphernalia to be distributed to a
3119	3119	minor or on or within 1,000 feet of any school property; and
3120	3120	(4) violation of subsection (d) is a:
3121	3121	(A) Class A nonperson misdemeanor, except as provided in
3122	3122	subsection (e)(4)(B) subparagraph (B); and
3123	3123	(B) nondrug severity level 9, nonperson felony if the trier of fact
3124	3124	makes a finding that the offender distributed or caused drug paraphernalia
3125	3125	to be distributed to a minor or on or within 1,000 feet of any school
3126	3126	property.
3127	3127	(f) For persons arrested and charged under subsection (a), bail shall
3128	3128	be at least $50,000 cash or surety, and such person shall not be released
3129	3129	upon the person's own recognizance pursuant to K.S.A. 22-2802, and
3130	3130	amendments thereto, unless the court determines, on the record, that the
3131	3131	1
3132	3132	2
3133	3133	3
3134	3134	4
3135	3135	5
3136	3136	6
3137	3137	7
3138	3138	8
3139	3139	9
3140	3140	10
3141	3141	11
3142	3142	12
3143	3143	13
3144	3144	14
3145	3145	15
3146	3146	16
3147	3147	17
3148	3148	18
3149	3149	19
3150	3150	20
3151	3151	21
3152	3152	22
3153	3153	23
3154	3154	24
3155	3155	25
3156	3156	26
3157	3157	27
3158	3158	28
3159	3159	29
3160	3160	30
3161	3161	31
3162	3162	32
3163	3163	33
3164	3164	34
3165	3165	35
3166	3166	36
3167	3167	37
3168	3168	38
3169	3169	39
3170	3170	40
3171	3171	41
3172	3172	42
3173	3173	43 SB 555 38
3174	3174	defendant is not likely to re-offend, the court imposes pretrial supervision
3175	3175	or the defendant agrees to participate in a licensed or certified drug
3176	3176	treatment program.
3177	3177	(g) The provisions of subsection (c) shall not apply to any medical
3178	3178	cannabis operator, as such term is defined in section 2, and amendments
3179	3179	thereto, whose distribution or manufacture is used solely to distribute or
3180	3180	produce medical cannabis or medical cannabis products, as such terms
3181	3181	are defined in section 2, and amendments thereto, in a manner authorized
3182	3182	by the medical cannabis pilot program act, section 1 et seq., and
3183	3183	amendments thereto.
3184	3184	(h) As used in this section, "or under circumstances where one
3185	3185	reasonably should know" that an item will be used in violation of this
3186	3186	section, shall include, but not be limited to, the following:
3187	3187	(1) Actual knowledge from prior experience or statements by
3188	3188	customers;
3189	3189	(2) inappropriate or impractical design for alleged legitimate use;
3190	3190	(3) receipt of packaging material, advertising information or other
3191	3191	manufacturer supplied information regarding the item's use as drug
3192	3192	paraphernalia; or
3193	3193	(4) receipt of a written warning from a law enforcement or
3194	3194	prosecutorial agency having jurisdiction that the item has been previously
3195	3195	determined to have been designed specifically for use as drug
3196	3196	paraphernalia.
3197	3197	Sec. 48. K.S.A. 23-3201 is hereby amended to read as follows: 23-
3198	3198	3201. (a) The court shall determine legal custody, residency and parenting
3199	3199	time of a child in accordance with the best interests of the child.
3200	3200	(b) The court shall not consider the fact that a parent consumes
3201	3201	medical cannabis or medical cannabis products in accordance with the
3202	3202	medical cannabis pilot program act, section 1 et seq., and amendments
3203	3203	thereto, when determining the legal custody, residency or parenting time of
3204	3204	a child.
3205	3205	Sec. 49. K.S.A. 38-2269 is hereby amended to read as follows: 38-
3206	3206	2269. (a) When the child has been adjudicated to be a child in need of
3207	3207	care, the court may terminate parental rights or appoint a permanent
3208	3208	custodian when the court finds by clear and convincing evidence that the
3209	3209	parent is unfit by reason of conduct or condition which renders the parent
3210	3210	unable to care properly for a child and the conduct or condition is unlikely
3211	3211	to change in the foreseeable future.
3212	3212	(b) In making a determination of unfitness the court shall consider,
3213	3213	but is not limited to, the following, if applicable:
3214	3214	(1) Emotional illness, mental illness, mental deficiency or physical
3215	3215	disability of the parent, of such duration or nature as to render the parent
3216	3216	unable to care for the ongoing physical, mental and emotional needs of the
3217	3217	1
3218	3218	2
3219	3219	3
3220	3220	4
3221	3221	5
3222	3222	6
3223	3223	7
3224	3224	8
3225	3225	9
3226	3226	10
3227	3227	11
3228	3228	12
3229	3229	13
3230	3230	14
3231	3231	15
3232	3232	16
3233	3233	17
3234	3234	18
3235	3235	19
3236	3236	20
3237	3237	21
3238	3238	22
3239	3239	23
3240	3240	24
3241	3241	25
3242	3242	26
3243	3243	27
3244	3244	28
3245	3245	29
3246	3246	30
3247	3247	31
3248	3248	32
3249	3249	33
3250	3250	34
3251	3251	35
3252	3252	36
3253	3253	37
3254	3254	38
3255	3255	39
3256	3256	40
3257	3257	41
3258	3258	42
3259	3259	43 SB 555 39
3260	3260	child;
3261	3261	(2) conduct toward a child of a physically, emotionally or sexually
3262	3262	cruel or abusive nature;
3263	3263	(3) the use of intoxicating liquors or narcotic or dangerous drugs of
3264	3264	such duration or nature as to render the parent unable to care for the
3265	3265	ongoing physical, mental or emotional needs of the child, except that the
3266	3266	use of medical cannabis or medical cannabis products in accordance with
3267	3267	the medical cannabis pilot program act, section 1 et seq., and amendments
3268	3268	thereto, shall not be considered to render the parent unable to care for the
3269	3269	ongoing physical, mental or emotional needs of the child;
3270	3270	(4) physical, mental or emotional abuse or neglect or sexual abuse of
3271	3271	a child;
3272	3272	(5) conviction of a felony and imprisonment;
3273	3273	(6) unexplained injury or death of another child or stepchild of the
3274	3274	parent or any child in the care of the parent at the time of injury or death;
3275	3275	(7) failure of reasonable efforts made by appropriate public or private
3276	3276	agencies to rehabilitate the family;
3277	3277	(8) lack of effort on the part of the parent to adjust the parent's
3278	3278	circumstances, conduct or conditions to meet the needs of the child; and
3279	3279	(9) whether, as a result of the actions or inactions attributable to the
3280	3280	parent and one or more of the factors listed in subsection (c) apply, the
3281	3281	child has been in the custody of the secretary and placed with neither
3282	3282	parent for 15 of the most recent 22 months beginning 60 days after the
3283	3283	date on which a child in the secretary's custody was removed from the
3284	3284	child's home.
3285	3285	(c) In addition to the foregoing, when a child is not in the physical
3286	3286	custody of a parent, the court, shall consider, but is not limited to, the
3287	3287	following:
3288	3288	(1) Failure to assure care of the child in the parental home when able
3289	3289	to do so;
3290	3290	(2) failure to maintain regular visitation, contact or communication
3291	3291	with the child or with the custodian of the child;
3292	3292	(3) failure to carry out a reasonable plan approved by the court
3293	3293	directed toward the integration of the child into a parental home; and
3294	3294	(4) failure to pay a reasonable portion of the cost of substitute
3295	3295	physical care and maintenance based on ability to pay.
3296	3296	In making the above determination, the court may disregard incidental
3297	3297	visitations, contacts, communications or contributions.
3298	3298	(d) A finding of unfitness may be made as provided in this section if
3299	3299	the court finds that the parents have abandoned the child, the custody of
3300	3300	the child was surrendered pursuant to K.S.A. 38-2282, and amendments
3301	3301	thereto, or the child was left under such circumstances that the identity of
3302	3302	the parents is unknown and cannot be ascertained, despite diligent
3303	3303	1
3304	3304	2
3305	3305	3
3306	3306	4
3307	3307	5
3308	3308	6
3309	3309	7
3310	3310	8
3311	3311	9
3312	3312	10
3313	3313	11
3314	3314	12
3315	3315	13
3316	3316	14
3317	3317	15
3318	3318	16
3319	3319	17
3320	3320	18
3321	3321	19
3322	3322	20
3323	3323	21
3324	3324	22
3325	3325	23
3326	3326	24
3327	3327	25
3328	3328	26
3329	3329	27
3330	3330	28
3331	3331	29
3332	3332	30
3333	3333	31
3334	3334	32
3335	3335	33
3336	3336	34
3337	3337	35
3338	3338	36
3339	3339	37
3340	3340	38
3341	3341	39
3342	3342	40
3343	3343	41
3344	3344	42
3345	3345	43 SB 555 40
3346	3346	searching, and the parents have not come forward to claim the child within
3347	3347	three months after the child is found.
3348	3348	(e) If a person is convicted of a felony in which sexual intercourse
3349	3349	occurred, or if a juvenile is adjudicated a juvenile offender because of an
3350	3350	act which, if committed by an adult, would be a felony in which sexual
3351	3351	intercourse occurred, and as a result of the sexual intercourse, a child is
3352	3352	conceived, a finding of unfitness may be made.
3353	3353	(f) The existence of any one of the above factors standing alone may,
3354	3354	but does not necessarily, establish grounds for termination of parental
3355	3355	rights.
3356	3356	(g) (1) If the court makes a finding of unfitness, the court shall
3357	3357	consider whether termination of parental rights as requested in the petition
3358	3358	or motion is in the best interests of the child. In making the determination,
3359	3359	the court shall give primary consideration to the physical, mental and
3360	3360	emotional health of the child. If the physical, mental or emotional needs of
3361	3361	the child would best be served by termination of parental rights, the court
3362	3362	shall so order. A termination of parental rights under the code shall not
3363	3363	terminate the right of a child to inherit from or through a parent. Upon
3364	3364	such termination all rights of the parent to such child, including, such
3365	3365	parent's right to inherit from or through such child, shall cease.
3366	3366	(2) If the court terminates parental rights, the court may authorize
3367	3367	adoption pursuant to K.S.A. 38-2270, and amendments thereto,
3368	3368	appointment of a permanent custodian pursuant to K.S.A. 38-2272, and
3369	3369	amendments thereto, or continued permanency planning.
3370	3370	(3) If the court does not terminate parental rights, the court may
3371	3371	authorize appointment of a permanent custodian pursuant to K.S.A. 38-
3372	3372	2272, and amendments thereto, or continued permanency planning.
3373	3373	(h) If a parent is convicted of an offense as provided in K.S.A. 38-
3374	3374	2271(a)(7), and amendments thereto, or is adjudicated a juvenile offender
3375	3375	because of an act which if committed by an adult would be an offense as
3376	3376	provided in K.S.A. 38-2271(a)(7), and amendments thereto, and if the
3377	3377	victim was the other parent of a child, the court may disregard such
3378	3378	convicted or adjudicated parent's opinions or wishes in regard to the
3379	3379	placement of such child.
3380	3380	(i) A record shall be made of the proceedings.
3381	3381	(j) When adoption, proceedings to appoint a permanent custodian or
3382	3382	continued permanency planning has been authorized, the person or agency
3383	3383	awarded custody of the child shall within 30 days submit a written plan for
3384	3384	permanent placement which shall include measurable objectives and time
3385	3385	schedules.
3386	3386	Sec. 50. K.S.A. 44-501 is hereby amended to read as follows: 44-
3387	3387	501. (a) (1) Compensation for an injury shall be disallowed if such
3388	3388	injury to the employee results from:
3389	3389	1
3390	3390	2
3391	3391	3
3392	3392	4
3393	3393	5
3394	3394	6
3395	3395	7
3396	3396	8
3397	3397	9
3398	3398	10
3399	3399	11
3400	3400	12
3401	3401	13
3402	3402	14
3403	3403	15
3404	3404	16
3405	3405	17
3406	3406	18
3407	3407	19
3408	3408	20
3409	3409	21
3410	3410	22
3411	3411	23
3412	3412	24
3413	3413	25
3414	3414	26
3415	3415	27
3416	3416	28
3417	3417	29
3418	3418	30
3419	3419	31
3420	3420	32
3421	3421	33
3422	3422	34
3423	3423	35
3424	3424	36
3425	3425	37
3426	3426	38
3427	3427	39
3428	3428	40
3429	3429	41
3430	3430	42
3431	3431	43 SB 555 41
3432	3432	(A) The employee's deliberate intention to cause such injury;
3433	3433	(B) the employee's willful failure to use a guard or protection against
3434	3434	accident or injury which is required pursuant to any statute and provided
3435	3435	for the employee;
3436	3436	(C) the employee's willful failure to use a reasonable and proper
3437	3437	guard and protection voluntarily furnished the employee by the employer;
3438	3438	(D) the employee's reckless violation of their employer's workplace
3439	3439	safety rules or regulations; or
3440	3440	(E) the employee's voluntary participation in fighting or horseplay
3441	3441	with a co-employee for any reason, work related or otherwise.
3442	3442	(2) Subparagraphs (B) and (C) of paragraph (1) of subsection
3443	3443	(a)Subsections (a)(1)(B) and (a)(1)(C) shall not apply when it was
3444	3444	reasonable under the totality of the circumstances to not use such
3445	3445	equipment, or if the employer approved the work engaged in at the time of
3446	3446	an accident or injury to be performed without such equipment.
3447	3447	(b) (1) (A) The employer shall not be liable under the workers
3448	3448	compensation act where the injury, disability or death was contributed to
3449	3449	by the employee's use or consumption of alcohol or any drugs, chemicals
3450	3450	or any other compounds or substances, including, but not limited to, any
3451	3451	drugs or medications which that are available to the public without a
3452	3452	prescription from a health care provider, prescription drugs or medications,
3453	3453	any form or type of narcotic drugs, marijuana, stimulants, depressants or
3454	3454	hallucinogens.
3455	3455	(B) (i) In the case of drugs or medications which are available to the
3456	3456	public without a prescription from a health care provider and prescription
3457	3457	drugs or medications, compensation shall not be denied if the employee
3458	3458	can show that such drugs or medications were being taken or used in
3459	3459	therapeutic doses and there have been no prior incidences of the
3460	3460	employee's impairment on the job as the result of the use of such drugs or
3461	3461	medications within the previous 24 months.
3462	3462	(ii) In the case of cannabis, including any cannabis derivatives,
3463	3463	compensation shall not be denied if the employee holds a valid medical
3464	3464	cannabis certificate issued pursuant to the medical cannabis pilot
3465	3465	program act, section 1 et seq., and amendments thereto, such cannabis or
3466	3466	cannabis derivative was used in accordance with such act, and there has
3467	3467	been no prior incidence of the employee's impairment on the job as a
3468	3468	result of the use of such cannabis or cannabis derivative within the
3469	3469	immediately preceding 24 months.
3470	3470	(C) It shall be conclusively presumed that the employee was impaired
3471	3471	due to alcohol or drugs if it is shown that, at the time of the injury, the
3472	3472	employee had an alcohol concentration of .04 or more, or a GCMS
3473	3473	confirmatory test by quantitative analysis showing a concentration at or
3474	3474	above the levels shown on the following chart for the drugs of abuse listed:
3475	3475	1
3476	3476	2
3477	3477	3
3478	3478	4
3479	3479	5
3480	3480	6
3481	3481	7
3482	3482	8
3483	3483	9
3484	3484	10
3485	3485	11
3486	3486	12
3487	3487	13
3488	3488	14
3489	3489	15
3490	3490	16
3491	3491	17
3492	3492	18
3493	3493	19
3494	3494	20
3495	3495	21
3496	3496	22
3497	3497	23
3498	3498	24
3499	3499	25
3500	3500	26
3501	3501	27
3502	3502	28
3503	3503	29
3504	3504	30
3505	3505	31
3506	3506	32
3507	3507	33
3508	3508	34
3509	3509	35
3510	3510	36
3511	3511	37
3512	3512	38
3513	3513	39
3514	3514	40
3515	3515	41
3516	3516	42
3517	3517	43 SB 555 42
3518	3518	Confirmatory
3519	3519	test cutoff
3520	3520	levels (ng/ml)
3521	3521	Marijuana metabolite
3522	3522	1
3523	3523	..............................................................15
3524	3524	Cocaine metabolite
3525	3525	2
3526	3526	..................................................................150
3527	3527	Opiates:
3528	3528	Morphine .............................................................................2000
3529	3529	Codeine ...............................................................................2000
3530	3530	6-Acetylmorphine
3531	3531	43
3532	3532	..................................................................10 ng/ml
3533	3533	Phencyclidine ...........................................................................25
3534	3534	Amphetamines:
3535	3535	Amphetamine ......................................................................500
3536	3536	Methamphetamine
3537	3537	34
3538	3538	.............................................................500
3539	3539	1
3540	3540	Delta-9-tetrahydrocannabinol-9-carboxylic acid.
3541	3541	2
3542	3542	Benzoylecgonine.
3543	3543	3
3544	3544	Specimen must also contain amphetamine at a concentration greater
3545	3545	than or equal to 200 ng/mlTest for 6-AM when morphine concentration
3546	3546	exceeds 2,000 ng/ml.
3547	3547	4
3548	3548	Test for 6-AM when morphine concentration exceeds 2,000
3549	3549	ng/mlSpecimen must also contain amphetamine at a concentration
3550	3550	greater than or equal to 200 ng/ml.
3551	3551	(D) If it is shown that the employee was impaired pursuant to
3552	3552	subsection (b)(1)(C) at the time of the injury, there shall be a rebuttable
3553	3553	presumption that the accident, injury, disability or death was contributed to
3554	3554	by such impairment. The employee may overcome the presumption of
3555	3555	contribution by clear and convincing evidence.
3556	3556	(E) An employee's refusal to submit to a chemical test at the request
3557	3557	of the employer shall result in the forfeiture of benefits under the workers
3558	3558	compensation act if the employer had sufficient cause to suspect the use of
3559	3559	alcohol or drugs by the claimant or if the employer's policy clearly
3560	3560	authorizes post-injury testing.
3561	3561	(2) The results of a chemical test shall be admissible evidence to
3562	3562	prove impairment if the employer establishes that the testing was done
3563	3563	under any of the following circumstances:
3564	3564	(A) As a result of an employer mandated drug testing policy, in place
3565	3565	in writing prior to the date of accident or injury, requiring any worker to
3566	3566	submit to testing for drugs or alcohol;
3567	3567	(B) during an autopsy or in the normal course of medical treatment
3568	3568	for reasons related to the health and welfare of the injured worker and not
3569	3569	at the direction of the employer;
3570	3570	(C) the worker, prior to the date and time of the accident or injury,
3571	3571	gave written consent to the employer that the worker would voluntarily
3572	3572	submit to a chemical test for drugs or alcohol following any accident or
3573	3573	1
3574	3574	2
3575	3575	3
3576	3576	4
3577	3577	5
3578	3578	6
3579	3579	7
3580	3580	8
3581	3581	9
3582	3582	10
3583	3583	11
3584	3584	12
3585	3585	13
3586	3586	14
3587	3587	15
3588	3588	16
3589	3589	17
3590	3590	18
3591	3591	19
3592	3592	20
3593	3593	21
3594	3594	22
3595	3595	23
3596	3596	24
3597	3597	25
3598	3598	26
3599	3599	27
3600	3600	28
3601	3601	29
3602	3602	30
3603	3603	31
3604	3604	32
3605	3605	33
3606	3606	34
3607	3607	35
3608	3608	36
3609	3609	37
3610	3610	38
3611	3611	39
3612	3612	40
3613	3613	41
3614	3614	42
3615	3615	43 SB 555 43
3616	3616	injury;
3617	3617	(D) the worker voluntarily agrees to submit to a chemical test for
3618	3618	drugs or alcohol following any accident or injury; or
3619	3619	(E) as a result of federal or state law or a federal or state rule or
3620	3620	regulation having the force and effect of law requiring a post-injury testing
3621	3621	program and such required program was properly implemented at the time
3622	3622	of testing.
3623	3623	(3) Notwithstanding subsection (b)(2), the results of a chemical test
3624	3624	performed on a sample collected by an employer shall not be admissible
3625	3625	evidence to prove impairment unless the following conditions are met:
3626	3626	(A) The test sample was collected within a reasonable time following
3627	3627	the accident or injury;
3628	3628	(B) the collecting and labeling of the test sample was performed by or
3629	3629	under the supervision of a licensed health care professional;
3630	3630	(C) the test was performed by a laboratory approved by the United
3631	3631	States department of health and human services or licensed by the
3632	3632	department of health and environment, except that a blood sample may be
3633	3633	tested for alcohol content by a laboratory commonly used for that purpose
3634	3634	by state law enforcement agencies;
3635	3635	(D) the test was confirmed by gas chromatography-mass
3636	3636	spectroscopy or other comparably reliable analytical method, except that
3637	3637	no such confirmation is required for a blood alcohol sample;
3638	3638	(E) the foundation evidence must establish, beyond a reasonable
3639	3639	doubt, that the test results were from the sample taken from the employee;
3640	3640	and
3641	3641	(F) a split sample sufficient for testing shall be retained and made
3642	3642	available to the employee within 48 hours of a positive test.
3643	3643	(c) (1) Except as provided in paragraph (2), compensation shall not
3644	3644	be paid in case of coronary or coronary artery disease or cerebrovascular
3645	3645	injury unless it is shown that the exertion of the work necessary to
3646	3646	precipitate the disability was more than the employee's usual work in the
3647	3647	course of the employee's regular employment.
3648	3648	(2) For events occurring on or after July 1, 2014, in the case of a
3649	3649	firefighter as defined by K.S.A. 40-1709(b)(1), and amendments thereto,
3650	3650	or a law enforcement officer as defined by K.S.A. 74-5602, and
3651	3651	amendments thereto, coronary or coronary artery disease or
3652	3652	cerebrovascular injury shall be compensable if:
3653	3653	(A) The injury can be identified as caused by a specific event
3654	3654	occurring in the course and scope of employment;
3655	3655	(B) the coronary or cerebrovascular injury occurred within 24 hours
3656	3656	of the specific event; and
3657	3657	(C) the specific event was the prevailing factor in causing the
3658	3658	coronary or coronary artery disease or cerebrovascular injury.
3659	3659	1
3660	3660	2
3661	3661	3
3662	3662	4
3663	3663	5
3664	3664	6
3665	3665	7
3666	3666	8
3667	3667	9
3668	3668	10
3669	3669	11
3670	3670	12
3671	3671	13
3672	3672	14
3673	3673	15
3674	3674	16
3675	3675	17
3676	3676	18
3677	3677	19
3678	3678	20
3679	3679	21
3680	3680	22
3681	3681	23
3682	3682	24
3683	3683	25
3684	3684	26
3685	3685	27
3686	3686	28
3687	3687	29
3688	3688	30
3689	3689	31
3690	3690	32
3691	3691	33
3692	3692	34
3693	3693	35
3694	3694	36
3695	3695	37
3696	3696	38
3697	3697	39
3698	3698	40
3699	3699	41
3700	3700	42
3701	3701	43 SB 555 44
3702	3702	(d) Except as provided in the workers compensation act, no
3703	3703	construction design professional who is retained to perform professional
3704	3704	services on a construction project or any employee of a construction
3705	3705	design professional who is assisting or representing the construction
3706	3706	design professional in the performance of professional services on the site
3707	3707	of the construction project, shall be liable for any injury resulting from the
3708	3708	employer's failure to comply with safety standards on the construction
3709	3709	project for which compensation is recoverable under the workers
3710	3710	compensation act, unless responsibility for safety practices is specifically
3711	3711	assumed by contract. The immunity provided by this subsection to any
3712	3712	construction design professional shall not apply to the negligent
3713	3713	preparation of design plans or specifications.
3714	3714	(e) An award of compensation for permanent partial impairment,
3715	3715	work disability, or permanent total disability shall be reduced by the
3716	3716	amount of functional impairment determined to be preexisting. Any such
3717	3717	reduction shall not apply to temporary total disability, nor shall it apply to
3718	3718	compensation for medical treatment.
3719	3719	(1) Where workers compensation benefits have previously been
3720	3720	awarded through settlement or judicial or administrative determination in
3721	3721	Kansas, the percentage basis of the prior settlement or award shall
3722	3722	conclusively establish the amount of functional impairment determined to
3723	3723	be preexisting. Where workers compensation benefits have not previously
3724	3724	been awarded through settlement or judicial or administrative
3725	3725	determination in Kansas, the amount of preexisting functional impairment
3726	3726	shall be established by competent evidence.
3727	3727	(2) In all cases, the applicable reduction shall be calculated as
3728	3728	follows:
3729	3729	(A) If the preexisting impairment is the result of injury sustained
3730	3730	while working for the employer against whom workers compensation
3731	3731	benefits are currently being sought, any award of compensation shall be
3732	3732	reduced by the current dollar value attributable under the workers
3733	3733	compensation act to the percentage of functional impairment determined to
3734	3734	be preexisting. The "current dollar value" shall be calculated by
3735	3735	multiplying the percentage of preexisting impairment by the compensation
3736	3736	rate in effect on the date of the accident or injury against which the
3737	3737	reduction will be applied.
3738	3738	(B) In all other cases, the employer against whom benefits are
3739	3739	currently being sought shall be entitled to a credit for the percentage of
3740	3740	preexisting impairment.
3741	3741	(f) If the employee receives, whether periodically or by lump sum,
3742	3742	retirement benefits under the federal social security act or retirement
3743	3743	benefits from any other retirement system, program, policy or plan which
3744	3744	is provided by the employer against which the claim is being made, any
3745	3745	1
3746	3746	2
3747	3747	3
3748	3748	4
3749	3749	5
3750	3750	6
3751	3751	7
3752	3752	8
3753	3753	9
3754	3754	10
3755	3755	11
3756	3756	12
3757	3757	13
3758	3758	14
3759	3759	15
3760	3760	16
3761	3761	17
3762	3762	18
3763	3763	19
3764	3764	20
3765	3765	21
3766	3766	22
3767	3767	23
3768	3768	24
3769	3769	25
3770	3770	26
3771	3771	27
3772	3772	28
3773	3773	29
3774	3774	30
3775	3775	31
3776	3776	32
3777	3777	33
3778	3778	34
3779	3779	35
3780	3780	36
3781	3781	37
3782	3782	38
3783	3783	39
3784	3784	40
3785	3785	41
3786	3786	42
3787	3787	43 SB 555 45
3788	3788	compensation benefit payments which the employee is eligible to receive
3789	3789	under the workers compensation act for such claim shall be reduced by the
3790	3790	weekly equivalent amount of the total amount of all such retirement
3791	3791	benefits, less any portion of any such retirement benefit, other than
3792	3792	retirement benefits under the federal social security act, that is attributable
3793	3793	to payments or contributions made by the employee, but in no event shall
3794	3794	the workers compensation benefit be less than the workers compensation
3795	3795	benefit payable for the employee's percentage of functional impairment.
3796	3796	Where the employee elects to take retirement benefits in a lump sum, the
3797	3797	lump sum payment shall be amortized at the rate of 4% per year over the
3798	3798	employee's life expectancy to determine the weekly equivalent value of the
3799	3799	benefits.
3800	3800	Sec. 51. K.S.A. 2023 Supp. 65-1120 is hereby amended to read as
3801	3801	follows: 65-1120. (a) Grounds for disciplinary actions. The board may
3802	3802	deny, revoke, limit or suspend any license or authorization to practice
3803	3803	nursing as a registered professional nurse, as a licensed practical nurse, as
3804	3804	an advanced practice registered nurse or as a registered nurse anesthetist
3805	3805	that is issued by the board or applied for under this act, or may require the
3806	3806	licensee to attend a specific number of hours of continuing education in
3807	3807	addition to any hours the licensee may already be required to attend or
3808	3808	may publicly or privately censure a licensee or holder of a temporary
3809	3809	permit or authorization, if the applicant, licensee or holder of a temporary
3810	3810	permit or authorization is found after hearing:
3811	3811	(1) To be guilty of fraud or deceit in practicing nursing or in
3812	3812	procuring or attempting to procure a license to practice nursing;
3813	3813	(2) to have been guilty of a felony or to have been guilty of a
3814	3814	misdemeanor involving an illegal drug offense unless the applicant or
3815	3815	licensee establishes sufficient rehabilitation to warrant the public trust,
3816	3816	except that notwithstanding K.S.A. 74-120, and amendments thereto, no
3817	3817	license or authorization to practice nursing as a licensed professional
3818	3818	nurse, as a licensed practical nurse, as an advanced practice registered
3819	3819	nurse or registered nurse anesthetist shall be granted to a person with a
3820	3820	felony conviction for a crime against persons as specified in article 34 of
3821	3821	chapter 21 of the Kansas Statutes Annotated, prior to their repeal, or article
3822	3822	54 of chapter 21 of the Kansas Statutes Annotated, and amendments
3823	3823	thereto, or K.S.A. 21-6104, 21-6325, 21-6326 or 21-6418, and
3824	3824	amendments thereto;
3825	3825	(3) has been convicted or found guilty or has entered into an agreed
3826	3826	disposition of a misdemeanor offense related to the practice of nursing as
3827	3827	determined on a case-by-case basis;
3828	3828	(4) to have committed an act of professional incompetency as defined
3829	3829	in subsection (e);
3830	3830	(5) to be unable to practice with skill and safety due to current abuse
3831	3831	1
3832	3832	2
3833	3833	3
3834	3834	4
3835	3835	5
3836	3836	6
3837	3837	7
3838	3838	8
3839	3839	9
3840	3840	10
3841	3841	11
3842	3842	12
3843	3843	13
3844	3844	14
3845	3845	15
3846	3846	16
3847	3847	17
3848	3848	18
3849	3849	19
3850	3850	20
3851	3851	21
3852	3852	22
3853	3853	23
3854	3854	24
3855	3855	25
3856	3856	26
3857	3857	27
3858	3858	28
3859	3859	29
3860	3860	30
3861	3861	31
3862	3862	32
3863	3863	33
3864	3864	34
3865	3865	35
3866	3866	36
3867	3867	37
3868	3868	38
3869	3869	39
3870	3870	40
3871	3871	41
3872	3872	42
3873	3873	43 SB 555 46
3874	3874	of drugs or alcohol;
3875	3875	(6) to be a person who has been adjudged in need of a guardian or
3876	3876	conservator, or both, under the act for obtaining a guardian or conservator,
3877	3877	or both, and who has not been restored to capacity under that act;
3878	3878	(7) to be guilty of unprofessional conduct as defined by rules and
3879	3879	regulations of the board;
3880	3880	(8) to have willfully or repeatedly violated the provisions of the
3881	3881	Kansas nurse practice act or any rules and regulations adopted pursuant to
3882	3882	that act, including K.S.A. 65-1114 and 65-1122, and amendments thereto;
3883	3883	(9) to have a license to practice nursing as a registered nurse or as a
3884	3884	practical nurse denied, revoked, limited or suspended, or to be publicly or
3885	3885	privately censured, by a licensing authority of another state, agency of the
3886	3886	United States government, territory of the United States or country or to
3887	3887	have other disciplinary action taken against the applicant or licensee by a
3888	3888	licensing authority of another state, agency of the United States
3889	3889	government, territory of the United States or country. A certified copy of
3890	3890	the record or order of public or private censure, denial, suspension,
3891	3891	limitation, revocation or other disciplinary action of the licensing authority
3892	3892	of another state, agency of the United States government, territory of the
3893	3893	United States or country shall constitute prima facie evidence of such a
3894	3894	fact for purposes of this paragraph (9); or
3895	3895	(10) to have assisted suicide in violation of K.S.A. 21-3406, prior to
3896	3896	its repeal, or K.S.A. 21-5407, and amendments thereto, as established by
3897	3897	any of the following:
3898	3898	(A) A copy of the record of criminal conviction or plea of guilty for a
3899	3899	felony in violation of K.S.A. 21-3406, prior to its repeal, or K.S.A. 21-
3900	3900	5407, and amendments thereto.
3901	3901	(B) A copy of the record of a judgment of contempt of court for
3902	3902	violating an injunction issued under K.S.A. 60-4404, and amendments
3903	3903	thereto.
3904	3904	(C) A copy of the record of a judgment assessing damages under
3905	3905	K.S.A. 60-4405, and amendments thereto.
3906	3906	(b) Proceedings. Upon filing of a sworn complaint with the board
3907	3907	charging a person with having been guilty of any of the unlawful practices
3908	3908	specified in subsection (a), two or more members of the board shall
3909	3909	investigate the charges, or the board may designate and authorize an
3910	3910	employee or employees of the board to conduct an investigation. After
3911	3911	investigation, the board may institute charges. If an investigation, in the
3912	3912	opinion of the board, reveals reasonable grounds for believing the
3913	3913	applicant or licensee is guilty of the charges, the board shall fix a time and
3914	3914	place for proceedings, which shall be conducted in accordance with the
3915	3915	provisions of the Kansas administrative procedure act.
3916	3916	(c) Witnesses. No person shall be excused from testifying in any
3917	3917	1
3918	3918	2
3919	3919	3
3920	3920	4
3921	3921	5
3922	3922	6
3923	3923	7
3924	3924	8
3925	3925	9
3926	3926	10
3927	3927	11
3928	3928	12
3929	3929	13
3930	3930	14
3931	3931	15
3932	3932	16
3933	3933	17
3934	3934	18
3935	3935	19
3936	3936	20
3937	3937	21
3938	3938	22
3939	3939	23
3940	3940	24
3941	3941	25
3942	3942	26
3943	3943	27
3944	3944	28
3945	3945	29
3946	3946	30
3947	3947	31
3948	3948	32
3949	3949	33
3950	3950	34
3951	3951	35
3952	3952	36
3953	3953	37
3954	3954	38
3955	3955	39
3956	3956	40
3957	3957	41
3958	3958	42
3959	3959	43 SB 555 47
3960	3960	proceedings before the board under this act or in any civil proceedings
3961	3961	under this act before a court of competent jurisdiction on the ground that
3962	3962	such testimony may incriminate the person testifying, but such testimony
3963	3963	shall not be used against the person for the prosecution of any crime under
3964	3964	the laws of this state except the crime of perjury as defined in K.S.A. 21-
3965	3965	5903, and amendments thereto.
3966	3966	(d) Costs. If final agency action of the board in a proceeding under
3967	3967	this section is adverse to the applicant or licensee, the costs of the board's
3968	3968	proceedings shall be charged to the applicant or licensee as in ordinary
3969	3969	civil actions in the district court, but if the board is the unsuccessful party,
3970	3970	the costs shall be paid by the board. Witness fees and costs may be taxed
3971	3971	by the board according to the statutes relating to procedure in the district
3972	3972	court. All costs accrued by the board, when it is the successful party, and
3973	3973	which that the attorney general certifies cannot be collected from the
3974	3974	applicant or licensee shall be paid from the board of nursing fee fund. All
3975	3975	moneys collected following board proceedings shall be credited in full to
3976	3976	the board of nursing fee fund.
3977	3977	(e) Professional incompetency defined. As used in this section,
3978	3978	"professional incompetency" means:
3979	3979	(1) One or more instances involving failure to adhere to the
3980	3980	applicable standard of care to a degree which that constitutes gross
3981	3981	negligence, as determined by the board;
3982	3982	(2) repeated instances involving failure to adhere to the applicable
3983	3983	standard of care to a degree which that constitutes ordinary negligence, as
3984	3984	determined by the board; or
3985	3985	(3) a pattern of practice or other behavior which that demonstrates a
3986	3986	manifest incapacity or incompetence to practice nursing.
3987	3987	(f) Criminal justice information. The board upon request shall receive
3988	3988	from the Kansas bureau of investigation such criminal history record
3989	3989	information relating to arrests and criminal convictions as necessary for
3990	3990	the purpose of determining initial and continuing qualifications of
3991	3991	licensees of and applicants for licensure by the board.
3992	3992	(g) Medical cannabis exemption. The board shall not deny, revoke,
3993	3993	limit or suspend the license of any licensee or publicly or privately
3994	3994	censure any licensee for:
3995	3995	(1) Advising a patient about the possible benefits and risks of using
3996	3996	medical cannabis or that using medical cannabis may mitigate the
3997	3997	patient's symptoms; or
3998	3998	(2) any actions as a patient or caregiver holding a valid medical
3999	3999	cannabis ceertificate issued pursuant to the medical cannabis pilot
4000	4000	program act, section 1 et seq., and amendments thereto, including whether
4001	4001	the licensee possesses or has possessed or uses or has used medical
4002	4002	cannabis in accordance with such act.
4003	4003	1
4004	4004	2
4005	4005	3
4006	4006	4
4007	4007	5
4008	4008	6
4009	4009	7
4010	4010	8
4011	4011	9
4012	4012	10
4013	4013	11
4014	4014	12
4015	4015	13
4016	4016	14
4017	4017	15
4018	4018	16
4019	4019	17
4020	4020	18
4021	4021	19
4022	4022	20
4023	4023	21
4024	4024	22
4025	4025	23
4026	4026	24
4027	4027	25
4028	4028	26
4029	4029	27
4030	4030	28
4031	4031	29
4032	4032	30
4033	4033	31
4034	4034	32
4035	4035	33
4036	4036	34
4037	4037	35
4038	4038	36
4039	4039	37
4040	4040	38
4041	4041	39
4042	4042	40
4043	4043	41
4044	4044	42
4045	4045	43 SB 555 48
4046	4046	Sec. 52. K.S.A. 2023 Supp. 65-28b08 is hereby amended to read as
4047	4047	follows: 65-28b08. (a) The board may deny, revoke, limit or suspend any
4048	4048	license or authorization issued to a certified nurse-midwife to engage in
4049	4049	the independent practice of midwifery that is issued by the board or
4050	4050	applied for under this act, or may publicly censure a licensee or holder of a
4051	4051	temporary permit or authorization, if the applicant or licensee is found
4052	4052	after a hearing:
4053	4053	(1) To be guilty of fraud or deceit while engaging in the independent
4054	4054	practice of midwifery or in procuring or attempting to procure a license to
4055	4055	engage in the independent practice of midwifery;
4056	4056	(2) to have been found guilty of a felony or to have been found guilty
4057	4057	of a misdemeanor involving an illegal drug offense unless the applicant or
4058	4058	licensee establishes sufficient rehabilitation to warrant the public trust,
4059	4059	except that notwithstanding K.S.A. 74-120, and amendments thereto, no
4060	4060	license or authorization to practice and engage in the independent practice
4061	4061	of midwifery shall be granted to a person with a felony conviction for a
4062	4062	crime against persons as specified in article 34 of chapter 21 of the Kansas
4063	4063	Statutes Annotated, prior to its repeal, or article 54 of chapter 21 of the
4064	4064	Kansas Statutes Annotated, and amendments thereto, or K.S.A. 21-6104,
4065	4065	21-6325, 21-6326 or 21-6418, and amendments thereto;
4066	4066	(3) to have committed an act of professional incompetence as defined
4067	4067	in subsection (c);
4068	4068	(4) to be unable to practice the healing arts with reasonable skill and
4069	4069	safety by reason of impairment due to physical or mental illness or
4070	4070	condition or use of alcohol, drugs or controlled substances. All
4071	4071	information, reports, findings and other records relating to impairment
4072	4072	shall be confidential and not subject to discovery or release to any person
4073	4073	or entity outside of a board proceeding;
4074	4074	(5) to be a person who has been adjudged in need of a guardian or
4075	4075	conservator, or both, under the act for obtaining a guardian or conservator,
4076	4076	or both, and who has not been restored to capacity under that act;
4077	4077	(6) to be guilty of unprofessional conduct as defined by rules and
4078	4078	regulations of the board;
4079	4079	(7) to have willfully or repeatedly violated the provisions of the
4080	4080	Kansas nurse practice act or any rules and regulations adopted pursuant to
4081	4081	such act;
4082	4082	(8) to have a license to practice nursing as a registered nurse or as a
4083	4083	practical nurse denied, revoked, limited or suspended, or to have been
4084	4084	publicly or privately censured, by a licensing authority of another state,
4085	4085	agency of the United States government, territory of the United States or
4086	4086	country or to have other disciplinary action taken against the applicant or
4087	4087	licensee by a licensing authority of another state, agency of the United
4088	4088	States government, territory of the United States or country. A certified
4089	4089	1
4090	4090	2
4091	4091	3
4092	4092	4
4093	4093	5
4094	4094	6
4095	4095	7
4096	4096	8
4097	4097	9
4098	4098	10
4099	4099	11
4100	4100	12
4101	4101	13
4102	4102	14
4103	4103	15
4104	4104	16
4105	4105	17
4106	4106	18
4107	4107	19
4108	4108	20
4109	4109	21
4110	4110	22
4111	4111	23
4112	4112	24
4113	4113	25
4114	4114	26
4115	4115	27
4116	4116	28
4117	4117	29
4118	4118	30
4119	4119	31
4120	4120	32
4121	4121	33
4122	4122	34
4123	4123	35
4124	4124	36
4125	4125	37
4126	4126	38
4127	4127	39
4128	4128	40
4129	4129	41
4130	4130	42
4131	4131	43 SB 555 49
4132	4132	copy of the record or order of public or private censure, denial, suspension,
4133	4133	limitation, revocation or other disciplinary action of the licensing authority
4134	4134	of another state, agency of the United States government, territory of the
4135	4135	United States or country shall constitute prima facie evidence of such a
4136	4136	fact for purposes of this paragraph; or
4137	4137	(9) to have assisted suicide in violation of K.S.A. 21-3406, prior to its
4138	4138	repeal, or K.S.A. 21-5407, and amendments thereto, as established by any
4139	4139	of the following:
4140	4140	(A) A copy of the record of criminal conviction or plea of guilty to a
4141	4141	felony in violation of K.S.A. 21-3406, prior to its repeal, or K.S.A. 21-
4142	4142	5407, and amendments thereto;
4143	4143	(B) a copy of the record of a judgment of contempt of court for
4144	4144	violating an injunction issued under K.S.A. 60-4404, and amendments
4145	4145	thereto; or
4146	4146	(C) a copy of the record of a judgment assessing damages under
4147	4147	K.S.A. 60-4405, and amendments thereto.
4148	4148	(b) No person shall be excused from testifying in any proceedings
4149	4149	before the board under this act or in any civil proceedings under this act
4150	4150	before a court of competent jurisdiction on the ground that such testimony
4151	4151	may incriminate the person testifying, but such testimony shall not be used
4152	4152	against the person for the prosecution of any crime under the laws of this
4153	4153	state, except the crime of perjury as defined in K.S.A. 21-5903, and
4154	4154	amendments thereto.
4155	4155	(c) The board shall not deny, revoke, limit or suspend the license or
4156	4156	authorization issued to a certified nurse-midwife or publicly or privately
4157	4157	censure a certified nurse-midwife for:
4158	4158	(1) Advising a patient about the possible benefits and risks of using
4159	4159	medical cannabis or that using medical cannabis may mitigate the
4160	4160	patient's symptoms; or
4161	4161	(2) any actions as a patient or caregiver holding a valid medical
4162	4162	cannabis certificate issued pursuant to the medical cannabis pilot
4163	4163	program act, section 1 et seq., and amendments thereto, including whether
4164	4164	the licensee possesses or has possessed or uses or has used medical
4165	4165	cannabis in accordance with such act.
4166	4166	(d) As used in this section, "professional incompetency" means:
4167	4167	(1) One or more instances involving failure to adhere to the
4168	4168	applicable standard of care to a degree which that constitutes gross
4169	4169	negligence, as determined by the board;
4170	4170	(2) repeated instances involving failure to adhere to the applicable
4171	4171	standard of care to a degree which that constitutes ordinary negligence, as
4172	4172	determined by the board; or
4173	4173	(3) a pattern of practice or other behavior which that demonstrates a
4174	4174	manifest incapacity or incompetence to engage in the independent practice
4175	4175	1
4176	4176	2
4177	4177	3
4178	4178	4
4179	4179	5
4180	4180	6
4181	4181	7
4182	4182	8
4183	4183	9
4184	4184	10
4185	4185	11
4186	4186	12
4187	4187	13
4188	4188	14
4189	4189	15
4190	4190	16
4191	4191	17
4192	4192	18
4193	4193	19
4194	4194	20
4195	4195	21
4196	4196	22
4197	4197	23
4198	4198	24
4199	4199	25
4200	4200	26
4201	4201	27
4202	4202	28
4203	4203	29
4204	4204	30
4205	4205	31
4206	4206	32
4207	4207	33
4208	4208	34
4209	4209	35
4210	4210	36
4211	4211	37
4212	4212	38
4213	4213	39
4214	4214	40
4215	4215	41
4216	4216	42
4217	4217	43 SB 555 50
4218	4218	of midwifery.
4219	4219	(d)(e) The board, upon request, shall receive from the Kansas bureau
4220	4220	of investigation such criminal history record information relating to arrests
4221	4221	and criminal convictions, as necessary, for the purpose of determining
4222	4222	initial and continuing qualifications of licensees and applicants for
4223	4223	licensure by the board.
4224	4224	Sec. 53. K.S.A. 79-5201 is hereby amended to read as follows: 79-
4225	4225	5201. As used in this act article 52 of chapter 79 of the Kansas Statutes
4226	4226	Annotated, and amendments thereto:
4227	4227	(a) "Marijuana" means any marijuana, whether real or counterfeit, as
4228	4228	defined by K.S.A. 21-5701, and amendments thereto, which is held,
4229	4229	possessed, transported, transferred, sold or offered to be sold in violation
4230	4230	of the laws of Kansas;
4231	4231	(b) "Controlled substance" means any drug or substance, whether real
4232	4232	or counterfeit, as defined by K.S.A. 21-5701, and amendments thereto,
4233	4233	which is held, possessed, transported, transferred, sold or offered to be
4234	4234	sold in violation of the laws of Kansas. Such term shall not include
4235	4235	marijuana;
4236	4236	(c)(b) "dealer" means any person who, in violation of Kansas law,
4237	4237	manufactures, produces, ships, transports or imports into Kansas or in any
4238	4238	manner acquires or possesses more than 28 grams of marijuana, or more
4239	4239	than one gram of any controlled substance, or 10 or more dosage units of
4240	4240	any controlled substance which that is not sold by weight;
4241	4241	(d)(c) "domestic marijuana plant" means any cannabis plant at any
4242	4242	level of growth which that is harvested or tended, manicured, irrigated,
4243	4243	fertilized or where there is other evidence that it has been treated in any
4244	4244	other way in an effort to enhance growth.
4245	4245	(d) "marijuana" means any marijuana, whether real or counterfeit,
4246	4246	as defined in K.S.A. 21-5701, and amendments thereto, that is held,
4247	4247	possessed, transported, transferred, sold or offered for sale in violation of
4248	4248	the laws of Kansas; and
4249	4249	(e) "medical cannabis" means the same as defined in section 2, and
4250	4250	amendments thereto.
4251	4251	Sec. 54. K.S.A. 79-5210 is hereby amended to read as follows: 79-
4252	4252	5210. Nothing in this act requires persons registered under article 16 of
4253	4253	chapter 65 of the Kansas Statutes Annotated, and amendments thereto, or
4254	4254	otherwise lawfully in possession of marijuana, medical cannabis or a
4255	4255	controlled substance to pay the tax required under this act.
4256	4256	Sec. 55. K.S.A. 21-5703, 21-5705, 21-5706, 21-5707, 21-5709, 21-
4257	4257	5710, 23-3201, 38-2269, 44-501, 79-5201 and 79-5210 and K.S.A. 2023
4258	4258	Supp. 65-1120 and 65-28b08 are hereby repealed.
4259	4259	Sec. 56. This act shall take effect and be in force from and after its
4260	4260	publication in the Kansas register.
4261	4261	1
4262	4262	2
4263	4263	3
4264	4264	4
4265	4265	5
4266	4266	6
4267	4267	7
4268	4268	8
4269	4269	9
4270	4270	10
4271	4271	11
4272	4272	12
4273	4273	13
4274	4274	14
4275	4275	15
4276	4276	16
4277	4277	17
4278	4278	18
4279	4279	19
4280	4280	20
4281	4281	21
4282	4282	22
4283	4283	23
4284	4284	24
4285	4285	25
4286	4286	26
4287	4287	27
4288	4288	28
4289	4289	29
4290	4290	30
4291	4291	31
4292	4292	32
4293	4293	33
4294	4294	34
4295	4295	35
4296	4296	36
4297	4297	37
4298	4298	38
4299	4299	39
4300	4300	40
4301	4301	41
4302	4302	42
4303	4303	43